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ABSTRACT 
Cytochrome P450s are a superfamily of hemoproteins that mediate oxidation 
of many endogenous and foreign compounds. Cytochrome P450 2E1 (CYP2E1) is 
one of the isoforms that has been of particular interest for its relevance to chemical 
toxicity and alcohol-induced liver injury. Previous studies suggested that exposure to 
carbon tetrachloride (CCl4), a notorious hepatotoxin, or chronic alcohol consumption 
triggers CYP2E1 metabolism where free radicals are produced causing lipid 
peroxidation which may contribute to liver damage. In the present study, male 
SV/129/ter strain mice with CYP2E1 gene being disrupted (CYP2E 1 -knockout mice) 
have been used as a model to study the role of CYP2E1 in acute CCl4- and chronic 
ethanol-mediated hepatotoxicity. 
For the CCl4 study, CYP2El-knockout (K0) and wild-type (WT) mice were 
intraperitoneally injected with 1 ml/kg body weight of CCl4 or com oil. Upon 24 hr 
exposure, serum alanine aminotransferase (ALT) and aspartate aminotransferase 
(AST) activities, indicators of liver damage, were 422- and 125-fold respectively, 
higher in WT mice injected with CCl4 than their controls, whereas the ALT and AST 
activities in K 0 mice after the administration of CCl4 were remained normal. Also, as 
shown from the histological results, abnormalities and ballooning ofhepatocytes were 
found in WT mice but not in K 0 mice treated with CCl4. Moreover, accumulation of 
triglycerides was observed in liver cells in WT mice treated with CCl4 indicating their 
livers become fatty which is a common phenomenon of CCl4-mediated liver injury. 
However, no such finding was observed in K 0 mice. These results strongly 
demonstrate the significant role of CYP2E1 in mediating CCl4 hepatotoxicity. 
Furthermore, significant increase in lipid peroxidation, determined by the 
malondialdehyde formation in vitro and conjugated dienes production in vivo, was 
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observed in microsomes isolated from livers of WT mice but not in K 0 mice after 
treating with CCl4. Significant depletion of phospholipids in liver as a consequence of 
lipid peroxidation was also demonstrated in WT mice administered with CCl4. The 
phospholipid content in K 0 mice, on the other hand, was maintained without any 
significant change as compared with their controls. These results strongly support the 
involvement of CYP2E1 in CCl4-mediated liver injury caused by lipid peroxidation. 
For the ethanol study, K 0 and WT mice were pair-fed with control or ethanol 
liquid diet with carbohydrate isocalorically replacing ethanol for two months. It is 
surprising that both the ALT and AST levels of WT mice fed with ethanol fell within 
the normal ranges as previous studies revealed that chronic ethanol consumption 
induces alcoholic liver disease in rats, mice (C57 BL/6, BALB/C, C3H/HeJ, KK) as 
well as in human. Also, the ALT and AST levels were normal in CYP2El-deficient 
mice fed with ethanol. No noticeable liver injury as revealed by histological study 
was observed in all groups after chronic ethanol consumption. In addition, neither 
accumulation of triglycerides nor depletion of phospholipids was found in both WT 
and K 0 mice after 2 months of chronic ethanol consumption. The absence of liver 
injury in WT and K 0 mice after feeding with 20% ethanol derived calories ethanol 
diet is inconsistent with previous study that alcoholic liver injury was developed in 
other strains of mice as mentioned above. The lack of ethanol-induced liver injury in 
our SV/129/ter genetic background mouse models suggests that genetic factor is one 
of the necessary prerequisites for the development of significant alcohol-induced 
pathology. The reasons that SV/129/ter mice were insensitive to ethanol-induced liver 
injury however require future study to find out. 
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CHAPTER I Literature Review 
1. Introduction 
Cytochrome P450, which was originally so named because of the wavelength 
of the maximum absorption of the pigment, now represents a diverse and ubiquitous 
class of heme proteins that oxidatively metabolize many exogenous compounds as 
well as foreign compounds. In general, mammalian cytochrome P450s can be 
functionally ..divided into two groups: one group that participates in biochemical 
pathways leading to the synthesis of steroid hormones and those that primarily 
metabolize foreign chemicals or xenobiotics. Also, there is a recommended 
nomenclature system which classified this group of enzymes into different families 
and further subdivided into subfamilies. The isozymes that can metabolize exogenous 
compounds that most toxicologists are of interest are grouped into families 1-4. 
Scientists strive to characterize those enzymes for they are regarded to be able to 
perform important physiological as well as detoxifying function when the subject is 
challenged with xenobiotics. 
In this present study, efforts were made on the study of cytochrome P450 2E1 
(CYP2E1), which is one ofthe isozymes ofP450, from a toxicological point of view. 
This isozyme ofP450 is constitutively expressed in liver and many other extraheptic 
tissues. Its well conservancy and cell-specific distribution may suggest the critical 
and specific endogenous roles. In addition, it can be induced by a diverse set of 
chemicals with different structures including those potential carcinogens and in 
particular, its level can be strongly enhanced by chronic exposure to ethanol which 
suggests it may well relate to alcoholic liver disease (ALD) as it is considered as the 
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major component of the microsomal ethanol-oxidizing system (MEOS) (Lieber et al., 
1970; Koop et al., 1982). Moreover, many studies suggested that CYP2E1 is able to 
reduce dioxygen to reactive oxyradicals that might initiate membranous lipid 
peroxidation causing tissue damage. Scientists, hence, viewing CYP2El,s unique 
ability in activating potential carcinogens, have been striving to clarify the 
physiological role of this particular isozyme by using in vitro as well as in vivo 
models using various types of animals as subjects. 
Carbon tetrachloride, a commonly used industrial solvent, is one of the 
compounds that can be metabolized by CYP2E1 (Lieber, 1997). It is notoriously 
regarded as a procarcinogen with liver as the main site of injury. On the other hand, 
ethanol, the major constituent in alcoholic beverages, can be also metabolized by 
CYP2E1. Chronic consumption of alcohol may lead to the consequence of 
developing alcoholic liver diseases (ALD). These two compounds, have one thing in 
common that is both of them can be activated by CYP2E1. It has been hypothesized 
that the liver toxicity caused by carbon tetrachloride and ethanol might be due to the 
action of CYP2E1. Hence, a transgenic CYP2El-knockout mouse model, recently 
developed by Lee et al (1996), was employed in the present work to study the role of 
CYP2E1 in carbon tetrachloride- and ethanol-induced hepatotoxicity. 
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2. Background ofCytochrome P450 
2.1 Discovery 
About 4 decades ago, an enzyme system in the liver endoplasmic reticulum 
which was capable of oxidatively metabolizing certain xenobiotic compounds was 
first discovered which then marked the beginning of the story of cytochrome P450s 
(Axelrod, 1955; Brodie et al., 1955). Later in 1955, in the same enzyme system, 
dioxygenase reactions as well as mono-oxygenase reactions were demonstrated which 
utilized NADPH as a reductant (Hayaishi et al.’ 1955; Mason et al., 1955). However, 
in 1958, a reduced pigment in liver microsomes that had a characteristic absorption 
maximum at 450 nm after binding to carbon monoxide (CO) was first identified and 
isolated by Garfinkel (1958) and Klingenberg (1958)，who are generally accredited 
with the discovery of cytochrome P450. This pigment was further characterized as a 
hemoprotein of the b-type cytochrome class and was termed as cytochrome P450 
(P450), meaning for a pigment with an absorption at 450 nm (Omura and Sato, 1962; 
Omura and Sato, 1964a; 1964b). Over the next 20 years, through the efforts of 
protein isolation, purification and characterization of P450s, it was evidently proved 
that P450 existed in multiple forms, but also found in mammals and other species. 
Consequently, further investigation regarding the functions, characteristics, 
identification ofadditional forms ofP450 were started to be carried out. 
2.2 Tissue Distribution 
Since P450 was originally discovered in mammalian liver microsome, it was 
initially thought to be existed only in microsomes of animal tissue. It has been, 
however, subsequently found in many other organs and tissues ofvarious animals, and 
in some plants, fungi and bacteria. Now, over 230 individual P450s have been 
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characterized according to their protein sequences, and forms of these enzymes appear 
to be present in every class of biota, including mammals, birds, fish (Andersson and 
Forlin, 1992)，reptiles, amphibians, insects (Feyereisen, 1993; Cohen and Feyereisen, 
1995), plants (Bozak et al., 1990; Durst, 1991; Hallahan et al., 1992), bacteria and 
fungi (Nelson et al., 1993). The distribution ofP450 proteins in mammalian systems 
(Waterman, 1992) has been investigated in detail and it has been established that they 
are present mainly in the liver (Paine, 1981) but are also found in the kidney, lung 
(Smith et al., 1982; Arinc, 1993)，gonads, adrenals, brain (Wamer et al., 1994), nasal 
epithelium (Dahl and Hadley, 1991)，placenta (Pasanen and Pelkonen, 1989), 
pancreas, spleen, gastrointestinal tract (Kaminsky and Fasco, 1992) and skin (Mukhtar 
and Khan, 1989). Another interesting finding is that P450 is not only identified in 
microsomal fraction but also present in the mitochondria and all the mitochondrial 
forms ofP450 so far characterized function in the metabolism of endogenous steroid 
substrates with strict substrate specificity, however, they are not involved in 
metabolism of foreign compounds. 
The concentrations ofP450 of different forms in various tissues of mammalia 
were also concerned, for one reason which may be that this may supply insights to 
investigators, in particular, concerning the functions ofP450s. In Table 1.1 and Table 
1.2，the P450 content in various mammalian tissues and the P450 content in untreated 
rat liver microsomes are respectively presented. Undoubtedly, the distribution of 
P450s can be regarded as being ubiquitous, as they are very widely distributed among 
various forms of life, from primitive bacteria to highly developed mammals, 
especially as there are certainly many more P450s present in different species which 
have yet to be discovered. 
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Table 1.1 P450 content * in various mammalian tissues (Adapted from Vainio, 
1980). 
Mammal ian species 
Organ Rat Mouse Rabbit Guinea pig M a n 
Liver 0.22-0.92 0.39-1.10 0.81-1.70 0.43-1.45 0.26-1.02 
Kidney 0.05—0.21 0.40 0.14-0.36 0.32 0.03 
Lung 0.035 一 0.27-0.38 0.07 — 
Intestine 0.02—0.13 0.04 0.07-0.43 0.18 — 
Adrenal gland 0.50 — 1.20 2.0 0.23-0.54 
Testis • 0.05-0.10 0.24 0.04 0.078 0.005 
Skin 0.05 0.022 — — — 
Spleen 0.025 一 — 一 — 
Ovary — — 0.06 一 — 
Brain 0.025-0.051 — — 一 一 
Note: * expressed as nmoi /mg microsomal protein — data not available or not known. 
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Table 1.2 P450 content in untreated rat liver microsomes (Adapted from Funae 
and Imaoka, 1993) 
P450 family/subfamily Content ' Total^ Percentage^ 
C Y P l A i 0.001 I 
C Y P 1A2 0.011 j • : ‘ 
C Y P 2A1 0.008 1 • 」 . . 
C Y P 2A2 0.046 ) _ < ' • ‘ 
C Y P 2 B l 0-002 1 o a i 9 19 
C Y P 2B2 0.017 j 。 • 丄.^  
C Y P 2C6 0.88 、 
C Y P 2 C 1 1 0.437 
C Y P 2C12 0.002 ‘ G‘65C ^5 
C Y P 2C13 0.123 > 
C Y P 2E1 0.079 0.079 7.9 
C Y P 3A2 0.146 0.146 14.6 
C Y P 4A1 0.022 1 3 0 
C Y P 4A2 0.008 J ^ ' ^^^ 
Notes: a Expressed as nmol P450/mg prote in ; ^ Percentage of 
tota l P450 measured. 
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2.3 Structure and Functions 
The hepatic P450 system consists of a number of P450 isoforms with a 
varying degree of inter- and intra-substrate selectivity (Gonzalez, 1992). P450 
isoforms possess an identical prosthetic group, but different aproprotein structures 
which are responsible for the broad and overlapping substrate specificity (^ebert et 
al., 1989). This superfamily of enzymes probably exhibit a common structural 
framework although the substrate binding sites of individual isozymes are likely to be 
distinct. One of the axial ligands for the heme prosthetic group is provided by the 
thiol moiety "Of a conserved cysteine residue that co-ordinate the heme iron (Gonzalez 
and Gelboin, 1993). 
P450 can be on one hand classified according to their nucleotide sequences 
similarity into families and subfamilies (this wi l l be discussed in the next section). 
On the other hand, they can be categorized functionally into 2 major groups, one 
involved in steroid biosynthetic pathways and the other taking part in catabolic 
microsomal enzyme system found in liver and to some extent in extrahepatic tissues. 
The former group comprises families 17，19，21 and 22 with major occurrence in 
extrahepatic tissues whereas families 1 -4 primarily code for the latter group which is 
often found in the membrane fraction of endoplasmic reticulum (microsomes) with 
high concentration in liver (Gonzalez, 1989b). It is hardly surprising that P450 
metabolizes almost any chemical that enters the body. Also, it is the most abundant 
among all xenobiotic-metabolizing enzymes and has the broadest range of substrate 
specificity. The mammalian P450 enzymes are predominantly found in the 
endoplasmic reticulum (families 1-4，7，19,and 21) and mitochondria (families 11 and 
27) ofmost cells, though the greatest abundance is in the liver. 
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P450 working as a system, therefore, involves in various endobiotic and 
xenobiotic metabolic pathways and possesses at least four different types of activities, 
monooxygenase activity, oxidase activity, reductase activity and peroxygenase 
activity. The first activity, the so-called monooxygenase activity, can make inert 
chemicals undergo hydroxylations, epoxidations, N-, 0 - or S-dealkylations, 
deaminations, sulfoxidations, desulfurations and oxidative dehalogenations, in the 
presence of O2 and NADPH (Figure 1.1) (Geoptar et al., 1995). The second function 
ofP450 is its oxidase ability which can release the reduced oxygen species involving 
direct electron transfer from reduced P450 to molecular oxygen with the concomitant 
formation of superoxide anion radicals (C^..) and hydrogen peroxide (HjOj) 
(Estabrook and Werringloer, 1977; Geoptar et al., 1995). Under subcellular 
conditions of low oxygen tension, this may in tum produce extremely reactive 
hydroxy radicals ( OH) in the presence of NADPH (Figure 1.1). The third activity is 
the reductase activity which proceeds readily in the absence of O2 and involves direct 
electron transfer to reducible substrates, such as halogenated alkanes or quinones, to 
produce free radical intermediates (Figure 1.1) (Nebert et al., 1989; Murray et al., 
1990). Finally, P450 can function as peroxygenases in a variety of peroxide-
dependent substrate hydroxylation reactions (Ortiz de Montellano, 1986). A myriad 
of chemical reactions carried out by P450 are depicted in Figure 1.1. 
Moreover, it should be noticed that P450s are bound to the membrane of 
cellular endoplasmic reticulum by a hydrophobic amino-terminal peptide (Gonzalez 
and Gelboin, 1993). It is believed that a portion of the globular structure of these 
isozymes is embedded in the lipid bilayer, where this membrane localization is ideal 
for their function in metabolizing hydrophobic substrates in the presence of NADPH-
P450 reductase and cytochrome b^ (Gonzalez and Gelboin, 1993). 
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Type of reaction Example 
MONOOXYCFNASF 4rTTVTTV 
Hydroxybdon R-CH2^3 ^ R-CHOH-CH3 
一 o ~ ~ - O b 
0 / \ 
R2C=CR2 ^ R2C-CR2 
OH 1 
N-hydroxybiwn R-NH-C(=O)-CH3 R-N-C(=O)-CH3 
CklcaUcybuon R-O-CH3 ^ R-OH + CH O^ 
OXTn(SF. ArTTVTTV 
Aromadc h y d r o x y l a u o n 〈 〉 ~ * ^ ^ — 〈 〉 。 H 
•OH 
Eihanol oxidauon CH3-CH2-OH — CH3-CH=O 
OH 0 
atechol o x i d a t i o n 〈 ^ ^ O H ~ ^ ^ _ 〈 ^ c = Q 
RFPTJCTASF. ArTTVTTY 
Azoreduoion R-N=N-R. — R-NH: + R'-NH! 
Niut)rcduction { ^ ^ ~ N O 2 ^ ^ ^ ~ N H 2 
Reducdvc dehalogenadon CCl4_ ^ CHCl3 + HC1 
PEROXYGFNASE ArTrVTTY 
/ ~ A XOOH / ~ \ 
Toiucnc hydroxylation � \ ^ C H 3 ^ � J~CH:OH 
Figure 1.1 Examples of biotransformation reactions resulting from the different 
catalytic activities ofP450 (Adapted from Geoptar et aL, 1995). 
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2.4 Nomenclature of the P450 Superfamily 
As mentioned before, P450 exists as a group of enzymes rather than as a single 
form and there are now a considerable number of isozymes which have been 
identified and characterized. In order to rectify the confusion, the need for naming the 
various forms of P450 was hence emerged. A Committee on Standardized 
Nomenclature of the P450 Genes was formed in 1987 which first introduced the 
nomenclature of P450 genes should base on the percentages of amino acid sequence 
similarities fNebert et al., 1987). For those isozymes whose P450 protein sequences 
possessing at- least 40% identity are classified as belonging to the same family, while 
for those showing more than 55% homology in their protein sequences are further 
regarded as within a subfamily. However, there still shows a few exceptional cases. 
Under this nomenclature, P450 gene and cDNA are named in one way whereas 
its corresponding gene product, that is enzyme, and mRNA are named in an another 
way. It is recommended that, to name a P450 gene or cDNA, an italicized root 
symbol "CZP" is used to denote cytcohrome P450 which is followed by an Arabic 
number to designate the P450 family and a letter indicating the subfamily when two 
or more subfamilies are known to exist within that family. Then an Arabic number 
was placed behind them to represent the individual gene. For example, CYPlA2 is 
P450 belonging to family 1, subfamily A and isozyme 2. However, i f there is no 
second subfamily nor gene exists in a family, the subfamily and gene number need not 
to be included. For the P450s found in mouse and Drosophila, the case is little bit 
different. We wi l l name the mouse cDNA and gene with italicized root symbol “Qyp’， 
instead of "CYP". Also, the final number is generally preceded by a hyphen and "/?" 
is used to denote a pseudogene . Therefore, for the case of "CYPlA2" in mouse, we 
wi l l use “Cypla-2,, for its gene and cDNA. For naming mRNA and protein, on the 
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other hand, nonitalicized capital letter, that is "CYPlA2" in our example, wi l l be used 
for all species including mouse and Drosophila (Nelson et al, 1996). 
On the other hand, it is worth emphasizing that the Nomenclature Committee 
of the International Union of Biochemistry 0SICIUB) prefers the term "heme-thiolate 
protein" instead of cytochrome for P450 (Palmer and Reedujk, 1989)，for they are in 
fact not "cytochromes" in the true meaning of this terminology. 
Unti l October 18，1995, there were 491 P450 genes and 22 pseudogenes 
characterized, which are found in 85 eukaryote (including vertebrates, invertebrates, 
fungi and plants) and 20 prokaryote species. These genes have been described in 74 
gene families, of which 14 families exist in all mammals. These 14 families comprise 
26 mammalian subfamilies, of which 20 and 15 have been mapped in the human 
genome and the mouse genome, respectively CNelson et aL, 1996). With the growing 
understanding on these isozymes, more P450 genes may have been discovered and 
added up to the list until now and in the foreseeable future. 
3. Cytochrome P450 2E1 (CYP2E1) 
3.1 Discovery 
In 1968，Lieber and DeCarli discovered that the microsomal ethanol oxidation 
was enhanced after chronic treatment with ethanol suggesting the existence of an 
enzyme inducible by ethanol. This enzyme, named as cytochrome P450 2E1 
(CYP2E1), was further purified from liver microsomes of ethanol-treated rabbits in 
1982 by Koop and his colleagues (Koop et al., 1982; Koop and Coon, 1984). Later 
this unique form of enzyme was also purified and characterized from the liver of 
many mammalian species including rats (Ryan et al., 1985; Johansson et al., 1988)， 
mouse (Longo et al., 1993)，hamster (Puccini et al., 1992) and human (Wrighton et 
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aL, 1986; Wrighton et al., 1987). Only a single gene has been detected in the CYP2E 
subfamily in the rat, mouse and human, whereas in rabbits, a closely related gene with 
97% amino acid homology, designated CYP2E2, has been cloned (Khani et al., 1988; 
Porter et al, 1989). 
It was found that this unique purified CYP2E1 protein exists predominantly in 
the high spin state and its oxidized form possesses a major peak at 394 nm whereas its 
reduced form is at 412 nm and a reduced-CO spectrum maximum is observed at 451 
nm. Upon substrate binding the high spin peak is shifted to an absorbance maximum 
of420 nm (Kpop et al., 1982; Morgan et al., 1982). 
3.2 Tissue Distribution 
CYP2E1 is most abundantly found in the liver where it localizes 
predominantly in the perivenous region, in the four to five layers of hepatocytes 
surrounding the hepatic vein (Ingelman-Sundberg et al., 1988; Tsutsumi et al., 1989). 
Also, CYP2E1 is present in kidney where it exists predominantly in the cortex region 
(Ronis et al., 1991) and in the brain where it occurs in Bergmann glia cells in the 
cerebellum, in pyramidal cells in the hippocampus, in dopaminergic cells in the 
striatum, in endothelial cells in the vessel and in pyramidal cells in the cortex 
(Hansson et al., 1990). Low levels ofCYP2El are expressed in many other tissues, 
including testis and ovaries (Yang et al., 1991)，nasal mucosa (Ding and Coon, 1990)， 
lung (Yang et aL, 1991), small intestine (Shimizu et al., 1990), colon (Hakkak et aL, 
1996), umbilical vein endothelial cells (Farin et aL, 1994) and lymphocytes (Song et 
al., 1990). Within the cell, the highest concentrations of CYP2E1 are undoubtedly 
found in the endoplasmic reticulum although this protein has also been reported to 
12 
exist in the cell membrane and in lysosomal vesicles (Ronis et aL, 1988; Wu and 
Cederbaum, 1992). 
3.3 Substrates and Inducers 
Many substrates have been identified for CYP2E1 (Koop, 1992). Until 1997, 
there are at least 80 different chemicals shown to be metabolized by this isozyme 
(Table 1.3). Some of these are endogenous substrates, demonstrating the 
physiological role of CYP2E1. Most, however, are exogenous compounds. Not 
infrequently,^ the metabolites resulted after the bioactivation by CYP2E1 are more 
toxic than the precursors (Lieber, 1997). For instance, the oxidation of ethanol by 
CYP2E1 may result in hydroxyl radical production. Hence, it is suggested that the 
unique capacity of CYP2E1 is to activate many xenobiotic compounds to their toxic 
metabolites, often free radicals, thereby contributing to the resulting pathology. 
Of the various CYP2E1 substrates, the hydroxylation of p-nitrophenol is one 
of the most effective ways for monitoring the level of this enzyme. It has also been 
demonstrated, using cDNA-expressed human enzymes, that the conversion of p-
nitrophenol is catalyzed predominantly (at least 85%) by CYP2E1 (Tassaneeyakul et 
al., 1993). In addition, CYP2E1 is also an effective catalyst of reductive reactions. 
The formation of trichloromethyl radicals from CCl4 which can be enhanced by 
ethanol treatment was reported by Reinke et al (1988). From the list of substrates, we 
can obtain some insights on the general functions of CYP2E1. In fact, CYP2E1 is an 
inducible enzyme. It can be induced not only by ethanol, but also by some 
endogenous substrates such as acetone (Koop et al., 1985). It is evident that the level 
of CYP2E1 in the rat can fluctuate at least 20-fold, being dependent on the diet in 
combination with ethanol (Ronis et al., 1993). In man, the level of CYP2E1 among 
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Table 1.3 List of substrates that are metabolized or activated by CYP2E1. 
(Adapted from Lieber，1997) 
Substrate Subso^ te 







Glycerol* � L.l-Dichloroechylene 
l30propanol 
Mechanol 1,2-Dichloropropane 
f^ opanol iV>-Dimethylacecamide 
Pentanol .VuV-Dimechylformamide 
L-Phenylethanol〔to acecophenone) Eaflurane 
Armnatic compounds EniUu^ e (Ln vivo in humans) 
“ I,2-Epoxy-3^ utene 
Aceouninophen Ethane 
AniLine Ethyl carbaxnaxe 
Benzene Ethylene dichloride 
Bromobenzene Halothane 


















- . Vmyl bronaide tuiers 
Diethyl ether Nitrosamine3, azocompounds 
Mechyl i-butyl ether 
l,i.2,3,3,3-Hexafluoropropyl methyl ether Azoxymethane 
iV^ V-Dlethylnitrosamine 
_ ., • iV^ V-Dimechykutrosamine 
FaUyacuis Methylazoxymethanol 
Arachidonic acid u;-l and w-2 hydroxyUdon /V.Nitroso-2,3<toiechytaorphoUne 
iV-NitrosomechylbenzyUmine 
Lauric add w-L hydroxyiadon iV-NicrosopyrroLidine 
• iV-Nitroso6is(2oxopropyl)amine 
Reducible subscmies 
HaLogenated and ncnhaLogenated aikanes and aUcenes :.Bucymydroxyperoxide 
Acecoacetate* Carbon cetrachloride 
Acetol Chromium [CdyT)] 
Acetone* Cumyl hydroperoxide 
Acetorutrile (+• caudase) l3-Hydroperoxy-9,l l^ ctadecadienoic acid 
Acrylonitnle 15-Hydroperoxy-5.3,ll,i3^ icosatetraenoic acid 
Oxygen 
I.S-3ucadiene 
Chlorofonn (to glutathione cor\jugate) 
ChiorotQtm now-afBnity component) 
• Endogenous compounds. 
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different individuals varies at least 50-fold (Wrighton et al., 1986; EkstOm et al,, 
1989; Lucas et al., 1993). This may partly be due to distribution of genetic 
polymorphic variants of CYP2E1, but is probably to a large extent inherent in 
different induction levels, caused by environmental factors. For example, acetone, 
ethanol, pyridine, pyrazole and isoniazid are commonly used as CYP2E1 inducers in 
rodent models, where all undergo CYP2E1 -dependent metabolism. However, some 
exceptions to this role are evident. Acetaminophen, butadiene, chlorzoxazone and 
CCl4 are CYP2E1 substrates which do not induce the enzyme expression, whereas 
imidazole induces CYP2E1 but does not appear to be a substrate. It becomes evident 
that the expression of CYP2E1 is regulated by many factors. The regulatory 
mechanisms for CYP2E1 induction have been studied extensively in the rat, and the 
various mechanism that have been identified in this regulation are summarized in 
Table 1.4. Sometimes, the regulation of CYP2E1 may involve more than one single 
mechanism. For example, a single compound, acetone, might regulate CYP2E1 at 
several different levels, as illustrated by stabilization of the protein in rats, in vivo 
(Song et al., 1989), and by increased mRNA in rabbit hepatocytes (Kraner et al., 
1993). It is hence an undeniable that the regulation of CYP2E1 expression is 
complex. 
3.4 Toxicological Role of CYP2E1 
CYP2E1 activates a score of xenobiotics to highly hepatotoxic compounds. 
Accordingly, CYP2E1 has been the subject of much interest as a putative mediator of 
the carcinogenic and toxic effects of these compounds. This pertains for instance to 
CCl4. It is known that CCl4 exerts its toxicity after conversion to an active compound 
(trichloromethyl radical) in the microsomes, and alcohol pretreatment 
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Table 1.4 Levels for substrate- and hormonal-dependent induction of CYP2E1. 
(Adapted from Song et al,, 1989). 
Level Agent/Conditions Extent 
Transcription Starvation 3- to 4-fold 
Chronic ethanol 3- to 4-fold 
mRNA stabilization Diabetes 3-fold 
Translation efficiency Isoniazid 2-fold 







f \ > . 
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remarkably stimulates the toxicity of CCl4 (Hasumura et al., 1974). Moreover, 
evidence has accumulated indicating that CYP2E1 plays an important role in the 
metabolic activation of precarcinogens such as benzene (Johansson et al., 1988)， 
nitrosamines (Anderson et aL, 1992) and azoxymethane (Sohn et al., 1991) and in the 
hepatotoxicity exerted by nitrosamines (Yamazaki et al., 1992), acetaminophen (Hu et 
al, 1993), halothane (Gruenke et al., 1988), ethanol (Ingelman-Sundberg et al., 1994) 
and enflurane (Takagi et al., 1983). 
There has been much evidence suggesting that the toxicity associated with 
CYP2E1 involves the free radical production. Ethanol and CCl4 are two of the 
examples which are believed to exert their hepatotoxic effects by the formation of free 
radicals after CYP2E1 activation (Johansson et al., 1985; Albano et al., 1991; Reinke 
et al., 1991). The free radicals produced may in tum initiate lipid peroxidation 
contributing to oxidative stress in cells. However, the mechanisms relating CYP2E1-
dependent lipid peroxidation to tissue damage are still speculative and need great 
effort to work on. 
4. CYP2El-knockout Mouse Model 
In the past, the toxicological role of CYP2E1 in mediating chemical-induced 
liver injury was associated with indirect studies using inhibitors and/or inducers. To 
establish the direct relationship of CYP2El-dependent liver injury, an in vivo mouse 
model which lack CYP2E1 expression was created recently. Lee et al. (1996) isolated 
a 14.2 kb DNA fragment containing the entire cyp2e-l gene coding sequence from a 
SV/129 mouse genomic library. Then, they disrupted the gene and created the mice 
homozygous for the disrupted allele. The CYP2El-knockout mice were bom 
normally and appeared phenotypically indistinguishable from their wild-type (normal) 
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counterparts. This CYP2El-knockout mouse model can be used to study the role of 
CYP2E1 in chemical-induced toxicity. In fact, the CYP2El-knockout mouse model 
has been successfully used to confirm the role of CYP2E1 in acetaminophen-induced 
liver injury (Lee et al, 1996) and benzene-induced bone marrow toxicity (Valentine et 
al, 1996). Therefore, this mouse model was employed to study the role ofCYP2El in 
CCl4- and ethanol-induced liver toxicity. 
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Chapter II Carbon Tetrachloride (CClJ Study 
1. Introduction 
1.1 General Properties and Usage of CCl4 
Carbon tetrachloride (CCl4) is a clear, non-inflammable, heavy liquid which 
evaporates readily, giving a characteristic sweet odor. It is a halogenated hydrocarbon 
which is produced industrially by the chlorination of methane, propane, ethane, 
propene or carbon disulphide (Environmental Protection Agency, 1984). 
CCl4 has been found useful in serving as a grain fumigant, anthelmintic, 
rodenticide and solvent for oils, fats, rubber cements and resins and has also been 
widely used as a fire extinguishers and a dry-cleaning agent (McGregor and Lang, 
1996). However, as there has been increasing an number of reports demonstrating 
that exposure of CCl4 produces liver damage (Chopra et al., 1972; Ugazio et al, 1973; 
Recknagel et al, 1977; Bruckner et al, 1986; Recknagel et al., 1989)，CCl4 is no 
longer used for many domestic purposes. Yet, there are still some countries that 
permit its use as a household reagent or in fire extinguishers (Ruprah et al., 1985; 
Manno et al., 1996). Thus humans may be exposed to CCl4 in some occupational 
settings and in the general environment. 
1.2 Toxicological Aspects of CCl4 
CCl4 is a simple molecule and very fat-soluble compound which enters the 
body by inhalation, ingestion and dermal absorption readily (Timbrell, 1991). 
Numerous reports demonstrate that CCl4 has been shown to produce liver damage 
including centrilobular necrosis and fatty degeneration in various species (Chopra et 
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al” 1972; Ugazio et aL, 1973; Bruckner et aL, 1986; Recknagel et al., 1989). In 
human, many cases of acute CCl4 poisoning have been documented, mostly following 
occupational exposure to the solvent, but also after accidental ingestion or inhalation 
(Lachnit and Pietschmann, 1960; Campbell et al., 1980). It is therefore not surprising 
to leam that CCl4 is classified as a highly toxic compound and is an animal carcinogen 
and a potential human carcinogen and either inhalation or ingestion of CCl4 is 
harmful and may be fatal. The effects that are brought about after inhalation of CCl4 
vapor may include headache, nausea, vomiting, dizziness, drowsiness, irritation of 
respiratory tract, loss of consciousness whereas ingestion of CCl4 may cause nausea, 
vomiting, headache, dizziness, gastro-intestinal irritation, blurred vision and lowering 
of blood pressure (Raucy et aL, 1993). It should be noted that the major specific 
organs suffering from the damage after exposure to CCl4 include liver, kidney and 
lung (McGregor and Lang, 1996). In fact, liver toxicity as mediated by CCl4 has been 
ofgreatest concem as liver is the primary target site of i ts metabolism and is the most 
susceptible to the damage caused by CCl4 (Timbrell, 1991). 
1.3 Mechanism of CCI4 -induced Hepatotoxicity 
The biochemical mechanism of CCl4-induced liver injury has been studied 
extensively by a large number of investigators over many years. It is generally 
hypothesized that CCl4 has to undergo metabolic activation to a free radical 
intermediate, trichloromethyl radical (CCl3 ), in order to exert its full necrogenic 
potential (Ghoshal and Recknagel, 1965; Recknagel and Ghoshal, 1966a; Slater, 
1982). Nevertheless, from the investigation on studying the kinetic behavior 0fCCl3. 
in the presence of various biologically important substances such as amino acids, 
nucleotides and fatty acids, it was found that CClj' was in fact relatively unreactive 
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with such substances (Packer et al., 1978; 1980; 1981). Yet when the same reactions 
were studied in the presence of O:，formation of a highly reactive trichloromethyl 
peroxy radical, CCl3O2. was demonstrated. The resulted CCl3O2 reacts rapidly with 
endogenous compounds such as promethazine, ascorbate, p-carotene, vitamin E and 
polyunsaturated fatty acids (Packer et al., 1981; Slater, 1982a; Fomi et al., 1983) 
resulting to a large enhancement in the reaction rates. 
Leaming from the fact that C d f i 2 reacts in a much faster rate with 
polyunsaturated fatty acids than does CCl3., it is more likely that the major mechanism 
for the initia!ion of lipid peroxidation involves CCl3O2 instead of CCl3.. Also, since 
covalent binding by CCI3O2.�ifit occurs, is unlikely to survive experimental work-up 
procedures, then it appears possible that covalent binding observed after exposure to 
CCl4 results largely from CCI3.�and that the stimulation of l ip id peroxidation involves 
mainly CCl3CV (Slater, 1982b). The cascade of mechanisms responsible for the 
ultimate liver damage after CCl4 exposure, disruption ofplasma membrane and death 
ofthe cell, is summarized in Figure 2.1.1. 
CCl4-initiated lipid peroxidation, no matter being induced by CCV or CCl3O2, 
can lead to ultimate tissue damage. Broadly defined, lipid peroxidation is the 
metabolism of lipids through pathways involving intermediate formation of lipid 
peroxides, hydroperoxides and endoperoxides (Recknagel et al., 1989). The overall 
process of lipid peroxidation is very complex, yet the major events have been 
published (Recknagel et al., 1989). Briefly, the double allylic hydrogen atoms of 
polyenoic fatty acids are particularly susceptible to hydrogen abstraction reactions by 
free radicals. For attack by CCI3.�the products would be CHCl3 and a lipid free 
radical. Resonance of the free radical electron results in shift of a double bond and 
generation ofrelatively stable lipid conjugated dienes (Holman, 1954). The primary 
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Metabolic Activation 
CCI4 • CCl3- + Ch 
CCIg- + Protein, Unsaturated lipid - ^ Covalent binding 
CCl3_ + Polyunsaturated lipid - ^ Lipid Peroxidation 
CCl3_ + O2 ~ • CCl3〇2-
CCl3〇2. + Polyunsaturated lipid - ^ Lipid Peroxidation 
Lipid Peroxidation ~ • Membrane damage, 
Enzyme inactivation, 
Aldehyde & peroxide products 
formation 
Aldehydes _ ^ increased capillary permeability 
& lipid peroxidation Increased platelet aggregation 
Protein cross-linking 
Decreased DNA synthesis 
Decreased enzyme activities 
Figure2.1.1 The sequence of cellular events following the metabolism of carbon 
tetrachloride to a reactive free radical (Adapted from Timbrell, 1991). 
22 
reactive radical species produced after the initiating events by metabolism of CCl4 
interacts with polyunsaturated fatty acid (PUFA) to initiate a complex series of 
reactions that result in a variety of degradation products (Figure 2.1.2). Lipid radicals 
react very rapidly with molecular oxygen to form lipid peroxy radicals (LOO ), which, 
after abstraction of a hydrogen from a neighboring polyenoic fatty acid, form 
corresponding lipid hydroperoxides (LOOH). Lipid endoperoxides are also formed. 
These processes alone allow for a continuing chain reaction, since one new lipid 
radical appears for every lipid peroxy radical formed. 
The -.peroxidative metabolism of polyenoic fatty acyl side-chains of 
phospholipids has been of paramount concem in the pathobiology of lipid 
peroxidation because the structural phospholipids of cell membranes (endoplasmic 
reticulum (ER), mitochondria and so on) have a high density ofpolyenoic-fatty acyl 
side-chains (Bartley, 1964) and the peroxidative decomposition of membrane 
phospholipids (PL) has devastating biological consequences. It is suggested that 
when acute CCl4 poisoning occurs, since the lipid component o fER ofthe liver cells 
is broken down via the process of lipid peroxidation, the lipid molecules accumulate 
within the cytoplasm, starting within cistemae of the ER (Recknagel et al., 1989; 
Huether and McCance, 1996). Fatty liver develops because CCl4 poisoning blocks the 
synthesis oflipid-acceptor proteins (apoproteins) that normally bind with triglycerides 
to form lipoproteins, which are transported out of the cell (Recknagel et al., 1960; 
Pencil et al., 1984; Huether and McCance, 1996). Fatty liver is developed as 
triglycerides accumulate within the liver cells. The physiological effects of CCl4-
mediated injury are summarized in Figure 2.1.3. 
1.4 Role ofCytochrome P450 2E1 (CYP2E1) in CCl4-induced Hepatotoxicity 
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R- + PUFA ——• RH +PUFA. 
PUFA. + O2 ——• PUFA〇2-
PUFA〇2. + PUFAH (or XH) ~ ^ PUFAO2H + PUFA (or X.) 




Figure 2.1.2 A summary of events in lipid peroxidation (Adapted from Slater, 
1984). 
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Exposure to CCI4 
_ i _ 







Destruction of endoplasmic 
reticulum membrane 
t 
Decrease of protein synthesis 
t 
Decrease of lipoprotein secretion 
i 
Increase triglyceride content of liver cells 
i 
Fatty liver 
Figure 2.1.3 A summary of CCl4-mediated liver injury. (Adapted from Huether and 
McCance, 1996). 
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It has been a very long time for investigators to localize the region of CCl4 
metabolism in order to confirm whichever enzyme(s) is/are responsible for the 
metabolic bioactivation. In 1965，it was reported that CCl4 can stimulate lipid 
peroxidation in liver homogenates (Comporti et al, 1965) and in post-mitochondrial 
fractions (Ghoshal and Recknagel, 1965). It is then believed that the enzyme(s) 
responsible for the CCl4 metabolism would probably occur in the ER fraction 
(microsomes). Later, it was demonstrated that in the presence ofasource o fNADPH 
and CCl4, the liver microsomes would be able to stimulate lipid peroxidation 
suggesting th£ involvement of the NADPH-dependent cytochrome P450 system in the 
overall process (Slater, 1966b). 
Of the multiple forms of cytochrome P450 present in liver ER, CYP2E1 has 
been implicated as a key metabolising enzyme for CCl4 bioactivation and CCl4-
mediated liver injury in animal studies with CYP2E1 inducers. For example, the 
hepatotoxicity and sometimes the lethality of CCl4 can be potentiated by 
administration of ethanol, usually 16-18 hr prior to CCl4 exposure (Shibayama, 1988; 
Ray and Mehendale, 1990). The enhancement of CCl^-induced hepatotoxicity by 
ethanol pre-treatment suggests the important role played by CYP2E1 as it is the 
isozyme of cytochrome P450 that is ethanol-inducible and able to metabolize many 
small hepatotoxic and carcinogenic compounds (Johansson et al., 1988). In addition, 
methanol treatment induces CYP2El-mediated j^-nitrophenol activity, which appears 
to be responsible for the increased CCl4 metabolism and thus the increased 
hepatotoxcity o f CCl4 (Allis et al, 1996). Also, pre-treatment of animals with 
pyrazole，acetone or other aliphatic alcohol causes a 15- to 30-fold potentiation of 
CCl4-dependent hepatotoxicity when compared to untreated animals (Lindros et al., 
1990; Persson et al,, 1990). This increase in CCl4 activation is accompanied by a 
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parallel increase in immunoreactive CYP2E1 content in liver microsomes (Johansson 
et al., 1988) as well as a parallel increase in metabolism of two specific CYP2E1 
substrates, p-nitrophenol (Johansson and Ingelman-Sundberg, 1985) and N-
nitrosodimethylamine (Sipes et aL, 1973). These studies suggest that enhancement of 
CCl4 bioactivation and CCl4-dependent hepatotoxicity are observed in animals pre-
treated with CYP2E1 inducers. 
The possible involvement of CYP2E1 in the bioactivation of CCl4 is further 
supported by studies with CYP2E1 inhibitors and antibodies. For instance, 
disulfiram, 6ne of the known CYP2E1 inhibitors, was shown to block the 
hepatotoxicity mediated by treatment of CCl4 in rats (Brady et aL, 1991). Moreover, 
addition ofanti-2El IgG which binds to CYP2E1 protein specifically results in 80% 
inhibition of CCl4 reduction mediated by human liver microsomes (Guengerich et al., 
1991; Ekstrom et al., 1989). These studies suggest that CYP2E1 is required in 
bioactivation 0fCCl4 leading to liver injury. 
1.5 Objectives o f the Study 
Although substantial indirect evidence from studies with CYP2E1 inducers or 
inhibitors implicates the possible involvement of CYP2E1 in the bioactivation of CCl4 
and CCl4-induced liver damage, there is still lack of direct in vivo evidence to 
demonstrate the CYP2El-dependent CCl4-induced hepatotoxicity. Furthermore, the 
effects of inducers on CYP2E1 induction were found to be not specific recently. For 
example, in rats, ethanol treatment has been associated with increases in hepatic levels 
of CYP2E1, and other P450s, such as CYP2Bl/2 and CYP4A1 (Ma et al., 1993; 
Nanji et al., 1994). Also, in rat hepatocyte culture, ethanol increases cytochromes 
CYP3A in addition to CYP2Bl/2 and CYP2E1 (Sinclair et aL, 1991). Similarly, 
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administration of pyridine to rats induces not only CYP2E1 but CYP2Bl/2 
simultaneously (Park et al., 1992). Therefore, it is not clear i f the potentiation of 
CCl4-mediated liver injury is due to the effect of CYP2E1 induction alone or in 
addition to other P450s, such as CYP2Bl/2, CYP3A, and/or CYP4A1 upon ethanol or 
pyridine pretreatment. 
In this study, the involvement of CYP2E1 in CCl4-induced hepatotoxicity in 
vivo was investigated using the recently developed CYP2El-knockout mice which 
lack CYP2E1 expression (Lee et al., 1996). Also, the role of CYP2E1 in CCl4-
mediated lipid peroxidation which is considered as a starting point of toxic response 
to CCl4 was also studied. Moreover, the effects of CCl4 exposure on the levels of 
hepatic PL and TG were also studied to see i f there is any disturbance occurring in the 
hepatic lipid metabolism after CCl4-induced lipid peroxidation. I f CYP2E1 is in fact 
the early major determinant in CCl4-induced hepatotoxicity, mice which lack CYP2E1 
expression should be resistant to CCl4-induced lipid peroxidation and hence liver 
damage. 
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2. Materials and Methods 
2.1 Chemicals and Materials 
Carbon tetrachloride (99.8% purity), formalin, monobasic sodium phosphate, 
dibasic sodium phosphate, ethylenediaminetetraacetic acid (EDTA), sodium chloride 
CNfaCl), perchloric acid, sodium hydroxide fNaOH), pyrogallic acid and sulphuric acid 
were obtained from Riedel-de Haen (Germany). Com oil was obtained from Lion 
and Globe (Hong Kong). Ethanol, phosphoric acid, acetic acid, cyclohexane 
(SpectrosoL grade), methanol, chloroform, hexane, diethyl ether, toluene were 
obtained from BDH Laboratory Supplies (Dorset, England). Rat CYP2E1 ECL 
Westem blotting kit (Cat No. RPN 259) and 0.45 ^m nitrocellulose membranes were 
obtained from Amersham Life Sciences (Buckinghamshire, England). Al l other 
chemicals were obtained from Sigma Chemical Company (St. Louis, MO). 
2.2 Animals 
CYP2El-knockout (K0) mice and their wild-type (WT) counterparts are 
inbred strains on Sv/129/ter genetic background (Lee et aL, 1996). A pair ofparental 
stocks o f K O and WT mice were shipped from the National Cancer Institute fNational 
Institutes of Health, Bethesda, MD, USA). They were then bred and reared at the 
Chinese University of Hong Kong animal rooms on a 12 hr light/dark cycle (06:00-
18:00) period. Animals were fed Laboratory Diet™ Brand Mouse Diet #5015 (PMI 
Nutrition Inc., St. Louis, MO) and chlorinated tap water ad libitum. 
2.3 Acute CCl4 Treatment 
Male K 0 and their WT counterparts (20-30 g, 10-12 week old) were 
acclimatized for at least 1 week prior to the experiments. The WT and K 0 mice (n = 
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5 per group) were intraperitoneally injected with 1 ml/kg body weight CCl4 (10% 
solution in com oil). Controls for each group were injected with the com oil vehicle 
only. After 24 hr, mice were sacrificed by decapitation and blood was collected into 
1.5 ml eppendorf tubes. Serum was obtained after the blood was allowed to clot at 
room temperature for 30 min and centrifuged at 3,000 rpm for 20 min. The whole 
liver was excised, weighed, and a small section (〜1 cm' wide) was removed from the 
median lobe and fixed in 10% formalin in phosphate buffered saline (PBS) for 
histopathological examination. The remaining liver lobes were snapped frozen, 
wrapped in aluminium foil, and stored in liquid nitrogen until used. 
2.4 Preparation ofMicrosomal Fractions 
A portion of the liver (〜0.6 g) was homogenized in 0.6 ml of ice-cold 
homogenizing buffer (pH7.4) containing 10 mM Hepes, 1 mM EDTA, 1 mM DL-
dithiothreitol (DTT) and 10% (v/v) glycerol using a 1 ml-Telfon-glass hand-held 
homogenizer (Wheaton, USA). The whole liver homogenate was then centriftiged at 
10,000g (= 17,000 rpm) in a Beckman table-top ultracentrifuge (Model Optima™ 
TLX) equipped with a TLA 120.2 fixed angle rotor for 30 min. The supernatant was 
transferred to a new tube and centrifuged again at 100,000 g (= 55,000 rpm) for 40 
min. After the centrifugation, the supernatant was discarded and the pellet was 
resuspended in resuspension buffer (RB) containing 0.1 M potassium phosphate 
buffer (pH7.4), 1 mM DTT, and 20% (v/v) glycerol. This suspension is referred to 
the microsomes. The microsomal preparations were either used immediately for p-
nitrophenol assays, in vitro 2-thiobarbituric acid assay, conjugated-diene detection 
and microsomal phospholipid (PL) analyses or stored at -80。C until used for SDS-
PAGE analysis. 
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2.5 Determination ofMicrosomaI Protein Concentration 
The protein concentration in the microsomal preparation was determined 
according to the microassay method by Bradford (1976). Bradford reagent was 
prepared by dissolving 100 mg Coomassie Brilliant Blue G-250 in 50 ml 95% ethanol 
and 100 ml 85% (w/v) phosphoric acid. The reagent mixture was further diluted to a 
final volume of 1000 ml and was filtered before use. A standard protein stock 
solution was prepared by dissolving 0.2 g bovine serum albumin (BSA) in 100 ml 
distilled water. From this stock solution, five different concentrations ofBSA ranging 
from 10 to 100 fj_g was prepared in 0.1 ml o fRB in 1.5 ml eppendorf tubes. To 0.1 ml 
of diluted microsomal preparations or BSA standard solutions, 1 ml of Bradford 
reagent was added in a 1.5 ml-eppendorf. This reaction mixture was vortexed and 
incubated at room temperature for at least 2 min (^ 1 hr). The absorbance of each 
sample was measured at 595 nm using a Beckman DU7500 Spectrophotometer. A 
BSA standard curve was constructed by plotting the corresponding absorbance against 
the BSA protein concentrations (^ig). A typical BSA standard curve is shown in 
Appendix 1. The protein concentration in microsomal sample was calculated from the 
standard curve obtained. 
2.6 Determination of Serum Aminotransferase Activities 
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
activities, markers for hepatotoxicity, were determined enzymatically by the rate of 
NADH disappearance (Bergmeyer et al., 1978). Commercial ALT and AST kits (Cat. 
No. 59-UV for ALT and Cat. No. 58-UV for AST) which were based on the 
optimization procedure as suggested by Bergmeyer et al. (1978) were obtained from 
Sigma Chemical Company (St. Louis, MO). Thirty-five microliters of serum sample 
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was used for each assay. The ALT and AST assays were performed according to the 
manufacturer's directions. 
2.7 Liver Histology 
The CCl4-induced hepatic damage was examined by histological study. Liver 
sections ofapproximate 1 cm' wide were excised from the median lobe with a razor 
blade and the sections were subsequently fixed in 10% formalin buffered with IX 
PBS overnight and then transferred to 70% (v/v) ethanol. The liver sections were then 
placed in increasing concentrations of ethanol, 70%，80%, 95% (v/v), each for 1 hr 
and then followed by 3 changes of absolute ethanol each for 25 min for complete 
dehydration. After dehydration, the liver sections were cleared in 2 changes ofxylene 
each lasting for 25 min. Then the liver sections were transferred to 3 changes of 
molten paraffin each for 25 min and finally embedded in paraffin using a Thermolyne 
Histo-Center (Model II-N), USA. On the next day, the embedded liver sections were 
then sectioned with a microtome (Leica, Germany) in 7 ^im in thickness, mounted 
onto glass slides (Anchor, China) and dried in 60°C oven ovemight. On the following 
day，the glass slides with the dried liver sections were placed unidirectionally in a 
staining rack which was then completely immersed in different tanks of solutions 
following the sequences as shown in Figure 2.2.1. The hydrating steps were started 
from tank 1 to 7 in which the samples were immersed in each tank lasting for 3 min. 
The hydrated samples were then stained with hematoxylin (tank 8) for another 3 min. 
Then they were quickly but gently rinsed under a running tap and were quickly dipped 
into tank 9 and removed. Subsequently, the samples were soaked in tank 10 for 2 min 
and rinsed again under a running tap immediately. The sections were then stained 
with eosin (tank 11) for 5 min and rinsed briefly under running water. The sections 
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^^^ j J " ^ [ ^ ^^^ j J "> [ ^^^ j J " ^ [ ^ ^ + _ ^ + 8 0 % + 7 0 % + Hx + A . A . + S.T. 
^ _ _ ^ ” 
Xy l | ^ X y l • X y l + ^ + Abs + Abs + 95% + 80% + 7 0 % 令 E 
20 19 18 17 16 15 14 13 12 11 
Figure 2.2.1 Sequence of hematoxylin and eosin staining. Xy l = xylene, Abs = 
absolute ethanol, 95% = 95% ethanol, 80% = 80% ethanol, 70% = 70% ethanol, Hx = 
hematoxylin, A. A. = acidified alcohol, S. T. = Scott's Tap water, and E = eosin. 
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were dehydrated gradually by quickly dipping in 70%, 80%, and 90% ethanol from 
tank 12，13 and 14 respectively. The samples were then dehydrated in 3 changes of 
absolute ethanol (tanks 15-17) each for 3 min. After complete dehydration, the 
sections were cleared by soaking in 3 changes ofxylene (tanks 18-20) for 3 min each. 
A few drops of mountant (Canada Balasm) were placed onto the stained section which 
was then covered with a cover slip. The liver sections were then allowed to air dry for 
2-3 days and examined under a light microscope. Assessment of liver injury was 
performed with the help ofProfessor W. Y. Chan from the Department ofAnatomy, 
the Chinese University ofHong Kong. 
2.8 Hepatic Microsomal CYP2E1 Activity -p-nitrophenol Assay 
The catalytic activity of microsomal CYP2E1 was measured by p-nitrophenol 
(PNP) hydroxylation (Koop, 1986; 1990) with minor modifications. Reaction 
mixtures (final volume of 1 ml) contained 250 ^iM PNP, 0.1 M potassium phosphate 
buffer，pH6.8, and 1 mg ofmicrosomal protein. After the reaction mixtures were pre-
equilibrated at 37°C for 3 min, 1 mM NADPH was then added to the above reaction 
mixtures to initiate the reaction. At the end of 20 min, the reaction was stopped by the 
addition of 0.5 ml of 0.6 N perchloric acid. The reaction mixtures were then 
centrifuged at 1000g for 5 min using a Beckman centrifuge (Model GS-15R) equipped 
with S4180 rotor. One milliliter of supernatant was added to tubes containing 0.1 ml 
of 10 N NaOH. The amount of 4-nitrocatechol formed was determined by reading 
absorbance at 546 nm using a Genesys 5 spectrophotometer. An extinction 
coefficient of 9.53 mM-'cm-' was used to calculate the amount of 4-nitrocatechol 
formed in the samples (Reinke and Moyer, 1985). 
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2.9 SDS-PAGE and Western Blot Analysis 
Liver microsomes (15 ^ig protein) were electrophoretically separated on a 12% 
sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) according to Laemmli 
(1970). They were then electrophoretically transferred to 0.45 ^im nitrocellulose 
membrane by semi-dry method according to the manufacturer's instructions (Bio_ 
Rad). The levels of immunoreactive CYP2E1 protein present in hepatic microsomes 
were measured using a rat CYP2E1 ECL Westem blotting kit (Cat. No. RPN259) 
obtained from Amersham Life Sciences. The immunodetection procedure utilizes an 
anti-rat CYP2E1 (primary) antibody raised in rabbit, a biotinylated secondary 
antibody, a streptavidin-horseradish peroxidase conjugate and ECL Westem blotting 
detection reagents. The liver microsomes from isoniazid treated rats were provided in 
the rat CYP2E1 ECL Westem blotting kit and used as a positive control. Al l 
immunodetection steps were performed according to the manufacturer's directions. 
Positive immunoreactive signals were visualized by enhanced chemiluminescence on 
Hyperfilm™ ECL (Amersham Life Sciences). 
2.10 Detection ofLipid Peroxidation in vitro and in vivo 
2.10.1 In vitro Lipid Peroxidation - 2-Thiobarbituric acid (TBA) assay 
Hepatic microsomal lipid peroxidation resulting from metabolism of CCl4 in 
* o was performed with TBA assay according to the modification as done by Allis et 
a/. (1996). Microsomes were isolated from WT and K 0 mice as described in section 
2.4 without any prior CCl4 treatment. To this untreated microsomes (0.5 mg 
protein/ml), 2.36 mM CCl4 in absolute ethanol and 1.1 mM NADPH in a final volume 
of 1 ml were added. The reaction tubes were covered with aluminium foil and 
incubated at 37°C for 15 min. TBA assay was carried out by adding 0.5 ml samples 
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to 0.2 ml of 8% SDS, 1.5 ml of20% acetic acid solution (pH3.5), and 1.5 ml ofO.8% 
aqueous solution of TBA. The reaction mixture was made up to 4 ml with distilled 
water which was then heated in a water bath at 95°C for 1 hr. After cooling to room 
temperature, the tubes were centrifiiged at 4000 rpm for 10 min using a Beckman 
centrifuge (Model GS-15R) equipped with a S4180 rotor. After centrifugation, the 
supernatant was taken and its absorbance at 532 nm was measured by using a Genesys 
5 spectrophotometer. External standard was used by reacting 10 ^1 (= 8.9 ^g) of 1，1’ 
3，3-tetraethoxypropane with 44 ^1 of 1 M hydrochloric acid. Malondialdehyde 
(MDA) was produced after incubating the above mixture at 50°C for 1 hr and served 
as an external standard. Various concentrations of MDA standard solutions were 
prepared and were subjected to TBA assay as the samples. A standard curve was 
constructed and a typical standard curve is shown in Appendix 2. The amount of 
malondialdehyde (MDA) produced in vitro after metabolism 0fCCl4 was expressed as 
M D A equivalents (nmoles MDA per mg protein per min). 
2.10.2 In vivo Lipid Peroxidation - Microsomal Conjugated Dienes Detection 
The amount of microsomal conjugated dienes was determined according to 
Rao & Recknagel (1968) with slight modification. Two livers (〜2 g) were pooled as 
one sample and four volumes of ice-cold homogenizing buffer containing 0.3 M 
sucrose and 3 mM EDTA was added to the liver samples in a 30-ml Telfon-glass 
hand-held homogenizer (Wheaton, USA). The homogenate was centrifuged at 
10,000g for 20 min at 4°C in Hitachi high-speed centrifuge (Model Himac CR21) 
equipped with a R24A rotor. The supernatant was centrifuged again at a higher speed, 
100,000g for 40 min, using a Beckman ultracentrifuge (Model L7-55) equipped with a 
R2629 rotor. The supernatant was discarded and the wall of the centrifuge tube was 
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wiped clean with Q-tips to remove any white fat and droplets of remaining cytosolic 
solution. The centrifuge tube which contained the microsomal pellet was rinsed 
gently with 1 ml of methanol without disturbing the pellet. After decanting the 
methanol, another 2 ml of fresh methanol was added to the tube. The pellet was 
dislodged carefully with a long and hard toothpick from the centrifuge tube and 
transferred to a clean 50-ml Falcon tube. The centrifuge tube was again rinsed with 
another 2 ml of fresh methanol in order to ensure complete transfer of microsomes. A 
double volume of chloroform was added to the Falcon tube containing the 
microsomes." The microsomes were resuspended in methanol solution in the Falcon 
tube using a Telfon-glass hand-held homogenizer. The Falcon tube was then shaken 
vigorously to ensure complete lipid extraction from the microsome suspension. The 
l ipid extract was allowed to stand at room temperature for 20 min with occasionally 
mixing. Then the lipid extract was filtered through a funnel fitted with a multi-fold 
filter paper (Whatman No. 1) into a clean Falcon tube. The original Falcon tube 
containing the microsomal l ipid extract was rinsed with another 15 ml fresh 
chloroform:methanol (2:1，v/v) to ensure complete transfer of microsomal lipid 
extract. Ten milliliters of distilled water was added slowly to the Falcon tube holding 
the filtrate. The Falcon tube was inverted gently twice and centrifuged at l,OOOg 
using a Beckman centrifuge (Model GS-15R) equipped with a S4180 rotor for 20 min 
at room temperature. The upper layer and all f luffy materials in the interfaces were 
then aspirated with a vacuum pump. Ten milliliters of distilled water was added to 
the tube again slowly and the subsequent steps were repeated as above. Three 
milli l iters of the clear bottom organic layer containing the microsomal l ipid extract 
were transferred to a new test tube. The lipid extract in the tube was evaporated under 
a stream of nitrogen made oxygen free by bubbling it through a 1% pyrogallic acid 
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solution. The lipid residues were suspended in 3 ml of cyclohexane and 1 ml of 
which was transferred to a quartz cuvette. The amount of conjugated dienes in the 
lipid extract was scanned between 220 and 300 nm against cyclohexane as a reference 
using a Beckman DU7500 Spectrophotometer. An aliquot of 0.25 ml lipid extract 
was retained and transferred to another test-tube for lipid quantification as described 
below. 
The amount of lipid present in the microsomal lipid extract was quantified 
according to Rao and Recknagel (1968). Firstly, an oxidizing reagent was prepared 
by dissolving 5 g o f K j C r A in 10 ml of distilled water and was then made up to 250 
ml with concentrated H2SO4. The lipid standard solutions were prepared freshly by 
using com oil (Lion and Globe, Hong Kong) as a stock solution. Two hundred 
milligrams of com oil was dissolved in 100 ml of chloroform in a 100-ml volumetric 
flask. A series o f l ip id standard solutions of different concentrations ranging from 50 
to 1000 mg were prepared. The lipid standards and the samples containing 0.25 ml 
aliquot were evaporated under a stream of nitrogen made oxygen free by bubbling it 
through a 1% pyrogallic acid solution. Two milliliters of oxidizing reagent were 
added to each tube. After mixing the tubes by vortexing, they were heated in a boiling 
water bath for 15 min. The tubes were then cooled to room temperature and 2 ml of 
distilled water was added. The absorbance readings were read at 600 nm by using a 
Beckman DU7000 Spectrophotometer against distilled water as a blank. A standard 
curve for l ipid concentration was constructed by plotting absorbance at 600 nm 
against the weight of lipid. A typical standard curve for lipid concentration is shown 
in Appendix 3. The conjugated diene contents are reported as the absorbance at 233 
nm in a 1% solution through a 1-cm light path per mg lipid (Rao and Recknagel, 
1968). 
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2.11 Hepatic Lipid Fatty Acid Composition Analysis 
2.11.1 Lipid Extraction 
Total lipid was extracted from the liver according to Folch et al. (1956). 
Approximately 300 mg of liver was transferred to a clean 50-ml Falcon tube. Two 
milligrams of L-a-phosphatidylcholine diheptadecanoyl, internal standard of 
phospholipid (PL), and 1 mg of triheptadecanoin, internal standard of triglyceride 
(TG), were added to the Falcon tube. These internal standards were used to monitor 
the extraction efficiency. Chloroform/methanol (2:1，v/v) was added to the Falcon 
tube to a final volume o f l 5 ml. Three milliliters ofO.9% NaCl was added to the tube 
and the liver was homogenized using a polytron (Model PT-MR 3000 from 
Kinematica, Switzerland) for at least 1 min. The homogenate was mixed well by 
vortexing and was then centrifuged at 2500 rpm using a Beckman centrifuge (Model 
GS-15R) equipped with a S4180 rotor for 5 min. The bottom organic layer containing 
the total lipid from the liver was then carefully transferred to a clean test-tube and was 
used subsequently for thin layer chromatography. 
2.11.2 Thin Layer Chromatography (TLC) 
The total lipid extract prepared from 2.11.1 was evaporated under a stream of 
nitrogen. Two hundred microliters of chloroform were then added to resuspend the 
lipid extracts. A hundred microliter aliquot was applied onto a TLC plate (Model SIL 
G-25 UV254 from Macherey-Nagel GmbH & Co. KG) by using a 50 ^il-capillary tube 
(Sigma) and different classes of lipid were separated by TLC. A drop o fPL and TG 
internal standard was added in the middle of the TLC plate as a reference. Then, the 
TLC plate was developed in a solvent mixture ofhexane, diethyl ether and acetic acid 
in volume ratio of 80:20:1 for 45 min. The TLC plate was dried at room temperature 
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under a safety ventilation hood. The plate was sprayed briefly with a thin layer of 
fluorescent dye (2', 7'-dichlorofluorescein in 95% methanol) and dried at room 
temperature under a safety ventilation hood. The migrating positions of PL, 
cholesterol, free fatty acid, TG and cholesteryl ester were visualized under UV light. 
The areas corresponding to PL and TG were marked with a pencil and they were 
scratched out with a cutter and then transferred to different screw-cap methylation 
tubes. 
2.11.3 Methylation 
To esterify the lipids, the silica gels corresponding to PL and TG were 
removed from the TLC plate as done in section 2.11.2 and transferred to the labeled 
screw-cap methylation tube respectively for methylation. To each ofthe tubes, 1 ml 
of toluene and 2 ml of boron trifluoride-methanol were added. The samples were 
heated in a heating block (Thermolyne) at 90°C for 45 min. The tubes were cooled to 
room temperature and which were then individually added with 5 ml hexane and 1 ml 
distilled water. The tubes were mixed well by vortexing and centrifuged at 2500 rpm 
using a Beckman centrifuge (Model GS-15R) equipped with a S4180 rotor for 5 min. 
The upper clear organic layer was transferred to a clean test tube and was then 
evaporated under a stream of nitrogen using a nitrogen evaporator (Organization 
Associates, Inc, USA). One milliliter ofhexane (AnalaR grade) was added to suspend 
the PL while 200 ^il ofhexane was added to dissolve the TG. 
2.11.4 Gas Chromatography 
PL and TG of various carbon chain lengths were separated by gas 
chromatography after the methylation o fPL and TG (Section 2.11.3). The dissolved 
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PL and TG were transferred to different 2-ml clear crimp vials (Hewlett Packard, 
USA) and sealed with caps (Hewlett Packard, USA). Gas chromatography (GC) was 
performed on a Hewlett Packard 6890 Series GC System equipped with a flame 
ionization detector and a Hewlett Packard-EWOWax (Cross-Linked PEG) 30 m x 
0.32 mm x 0.5 ^im capillary column (Part No. 19091N-213). Samples were injected 
in 3 ^il aliquots by an autosampler and injections were run under a constant flow of 
1.3 ml/min nitrogen as a carrier gas and a timed protocol initiated with an oven 
temperature of 150。C for 1 min. The oven temperature was then programmed to 
increase at a rate of l5°C/min to 200°C. This temperature was hold for 2 min and was 
finally heated up to 250°C for 5 min at a rate of2°C/min. The temperature ofthe inlet 
and detector were 220°C and 275°C, respectively. For data acquisition and 
processing, the HP Chemstation software package implemented on a HP Vectra 
486/33VL was used. PL and TG profiles were reported according to the length of 
carbon chain in mg PL and TG per g liver respectively. 
2.12 Statistical Analysis 
Differences in treatment means for the two strains of mice were analyzed by 
Student's /-test using SigmaStat Advisory Statistical Software (SigmaStat version 




3.1 Mortality, Liver Weight and Liver Color 
In this experiment, 100% survival was noted in both wild-type (WT) and 
CYP2El-knockout (K0) mice administered 1 ml/kg CCl4 or com oil. A l l animals 
remained alive after 24 hr of CCl4 exposure. Administration of 1 mVkg CCl4 to both 
WT and K 0 mice caused no significant effect on the liver/body weight ratio between 
control and treated animals (Table 2.3.1). 
In the course of dissecting the livers from the experimental animals, distinct 
color differences were observed among livers obtained from WT and K 0 animals 
after CCl4 exposure (Figure 2.3.1). In WT mice, consistent pale orange color was 
found in the livers of these animals after CCl4 exposure and which was different from 
those of the com-oil treated animals in which a normal reddish-brown color was 
observed (Figure 2.3.1). The pale orange color observed in the livers o f W T animals 
was an apparent indication of fatty infiltration resulting from exposure to CCl4 
(Paquet and Kamphausen, 1975; Cunnane, 1987). In contrast, the pale orange color 
apparently was not observed in the livers o f K O animals after CCl4 treatment and the 
normal reddish-brown color which was similar to that observed in com oil control 
groups was found instead (Figure 2.3.1). These results suggest that CYP2E1 is 
involved in CCl4-induced fatty accumulation in livers of animals, although further 
biochemical quantification ofhepatic lipid levels in these animals is needed. 
3.2 Hepatotoxicity 
3.2.1 Serum ALT and AST activities 
ALT and AST are hepatic enzymes that are released into the bloodstream 
when liver cells are damaged. To assess the CCl4-induced liver injury in WT and K 0 
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Table 2.3.1 Effects of CCl4 treatment on liver weight in WT and K 0 mice. 
0/0 Liver weight (liver weight / body weight x 100%) 
Strain Com oil C ^ 
^ 4 .6 i0 .39~~ ‘ 4.3 ± 0.26 ^ ' “ 
K 0 3.8±0.21 3.7±0.41 ^^ 
WT and K 0 mice were treated for 24 hr either with 1 mVkg of CCl4 or com oil. Data 
are mean 士 SD of five determinations. Differences in mean values were analysed by 
Student's t-test {P < 0.05). NS, not significantly different {P > 0.05) from com oil 
(control) exposure. 
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Figure2.3.1 Representative of livers taken from WT and K 0 mice after 1 ml/kg 
CCl4 intraperitoneal injection. Consistent pale orange color was found in all the livers 
taken from CCl4-treated WT mice (n=5) whereas livers taken from K 0 mice (n=5) 
after CCl4 treatment remained normal reddish-brown color and were comparable to 
their com oil control. 
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mice，serum ALT and AST activities were measured as markers of liver injury after 
CCl4 exposure. In WT mice, CCl4 treatment resulted in marked increases of serum 
ALT and AST activities (Figures 2.3.2A and 2.3.2B)，and which were significantly 
different from those of the control groups. There were about 422- and 125-fold 
increases in ALT and AST activities respectively, in WT mice administered with CCl4 
when compared to its com oil control group. Remarkably, CCl4 treatment did not 
dramatically increase the ALT and AST (Figures 2.3.2A and 2.3.2B) activities in the 
serum o f K O mice. Furthermore, the serum ALT and AST activities in the com oil-
treated WT, “and com oil- and CCl4-treated K 0 mouse groups were fell within the 
normal range (Hall, 1992). These results indicate that CYP2E1 is the major factor 
involved in CCl4-mediated liver injury. 
3.2.2 Liver HistopathoIogy 
It is known that CCl4-induced hepatotoxicity is dose-dependent and 
characterized by centrilobular necrosis (Koch et al., 1974，Akahori et al., 1983， 
Daniluk et al., 1994，Rao et al., 1997). Similar results were observed in our studies in 
the WT mice. As shown in Figures 2.3.3A and 2.3.3B, a normal liver architecture 
was found in WT com-oil treated control group. Hepatocytes within the liver 
parenchyma were arranged into anastomozing plates of one cell thick radiating from 
the central vein of the lobules. Hepatic sinusoids were found between two 
anastomozing plates of hepatocytes. A single sublethal dose (1 ml/kg) of CCl^ 
administered to the WT animals caused histological abnormalities in centrilobular 
zones although the central vein appeared normal in size (Figures 2.3.3C and 2.3.3D). 
Scattered degenerating cells were found in the hepatic parenchyma. These cells 
became eosinophilic with a pyknotic nucleus. Some of these cells already had their 
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Figure 2.3.2 Serum alanine aminotransferase (panel A) and aspartate aminotransferase 
(panel B) activities in WT and K 0 mice after 24 hr exposure to 1 ml/kg CCl4 intraperitoneal 
injection. Data are mean 土 SD of five mice per group. Differences in mean values were 
analysed by Student's Mest (P < 0.05). *** Statistically different from com oil (control) 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































nucleus excluded, leaving the acidophilic body. In perivenular areas (areas 
surrounding the central vein), many liver cells were ballooned with multiple 
vacuolation in their cytoplasm. The arrangement of the anastomozing plates of 
hepatocytes was disrupted. The hepatic sinusoids appeared to be collapsing and was 
diminished in size. Infiltration of mononuclear inflammatory cells and fibrosis were 
however not obvious. In the K 0 mice, however, CCl4 treatment did not result in any 
noticeable histological changes (Figure 2.3.3F) when compared to either WT (Figures 
2.3.3A and 2.3.3B) or K 0 (Figure 2.3.3E) mice treated with com oil vehicle only. 
Thus the histological alterations were consistent with the serum enzyme findings and 
fUrther supported the hypothesis that CYP2E1 is the major factor involved in CCl4-
mediated liver injury. 
3.3 CYP2El-cataIyzed PNP Activities and CYP2E1 Protein Levels 
3.3.1 CYP2El-catalyzed PNP Activities 
Previous studies reported that CCl4 treatment in rodents (Tiemey et al., 1992) 
or in CYP2El-transfected HepG2 cell line (Dai and Cederbaum, 1995) labilizes 
CYP2E1，inactivating the CYP2El-catalyzed PNP enzyme activity and enhancing its 
degradation. Of the various substrates, the hydroxylation of j9-nitr0phen0l is most 
effective for monitoring the level of this enzyme (Dai and Cederbaum, 1993). In our 
study，liver microsomes isolated from the com oil-treated WT mouse group showed 
the basal level ofCYP2El-catalyzed PNP enzyme activity (Figure 2.3.4). Similar to 
earlier studies, CCl4 treatment caused a dramatic inhibition (93%) in PNP activity in 
WT mice after 24 hr of exposure (Figure 2.3.4). Although CYP2E1 protein was not 
expressed in K 0 mice (Lee et al., 1996 and Valentine et al., 1996), there was some 
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Figure 2.3.4 Effect of CCl4 treatment on CYP2El-catalysed ;7-nitr0phen0l 
hydroxylation. Mouse hepatic microsomes were prepared form com oil (hatched 
bars) or CCl4-treated (solid bars) mice. PNP hydroxylation was performed in a 
reaction mixture containing 1 mg protein and 250 ^iM PNP in 0.1 M potassium 
phosphate buffer (pH 6.8) under 37°C. Reaction was initiated by adding 1 mM 
NADPH and stopped 20 min after incubation. Data are mean 土 SD of five 
determinations. Differences in mean values were analyzed by Student's /-test {P < 
0.05). * * * Statistically different from com oil (control) exposure {P < 0.001). 
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mice indicating that this PNP activity was not catalyzed by CYP2E1 in these mice. 
This speculation seems further supported by the fact that CCl4 treatment had no 
significant inhibitory effect on the non-CYP2El-catalyzed PNP activity in the K 0 
mice (Figure 2.3.4). 
3.3.2 CYP2E1 Protein Levels 
Effect 0fCCl4treatment on CYP2E1 enzyme activity was further supported by 
the Westem blot analyses with rat anti-CYP2El IgG. An immunoreactive band of 
about 56 kDa expected for the CYP2E1 protein was found in WT control group 
treated with com oil (Figure 2.3.5A, lanes 1-4). This represents the constitutive basal 
level of CYP2E1 in the hepatic microsomes of WT mice. The 56 kDa 
immunoreactive CYP2E1 protein was dramatically reduced to non-detectable levels 
after CCl4 exposure in the WT group (Figure 2.3.5A, lanes 5-8) as compared to its 
control group (Figure 2.3.5A, lanes 1-4). The decrease in CYP2E1 protein correlated 
with the decrease in PNP activity (Figure 2.3.4). As expected, there was no 
immunoreactive CYP2E1 proteins detected in the liver microsomes o f K O mice either 
treated with com oil (Figure 2.3.5B, lanes 1-4) or CCl4 (Figure 2.3.5B, lanes 5-8) as 
the Cyp2el gene was disrupted and hence no CYP2E1 protein was produced in these 
K 0 mice (Lee et al., 1996; Valentine et al., 1996). 
3.4 Lipid Peroxidation 
3.4.1 In vitro Lipid Peroxidation 
Lipid peroxidation is often regarded as a typical type of cellular injury as 
caused by CCl4 (Recknagel et al, 1989). Levels of lipid peroxidation after CCl4 
treatment was monitored in vitro by measuring the amounts of malondialdehyde 
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Figure2.3.5 Western blot analysis of CYP2E1 expression in WT (panel A) and K 0 
(panel B) mouse livers after 24 hr exposure to CCl4. Liver microsomal proteins (15 ^g/lane) 
prepared from four com oil-treated (lanes 1-4) and four CCl4-treated (lanes 5-8) mice were 
subjected to SDS-PAGE and transferred to nitrocellulose membrane. Blots were probed with 
polyclonal rat anti-CYP2El. Isoniazid-treated rat liver microsomes were used as a positive 
control (panel B, +ve control). 
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(MDA) produced in hepatic microsomes from the decomposition of lipid 
endoperoxides during lipid peroxidation. 
Significant increase in the amount o f M D A was found in microsomes isolated 
from WT mice following CCl4 treatment in vitro (Figure 2.3.6). Also, the level of 
M D A formation in WT mice after control treatment in vitro was comparable to that 
determined in Allis et al. (1996). There was 78.8% increase in MDA levels in WT 
hepatic microsomes treated with CCl4 as compared to its controls. On the other hand, 
no significant change in the levels of MDA was found in K 0 mice after CCl4 
treatment. This result indicates that CYP2E1 is required in CCl4-induced lipid 
peroxidation. 
3.4.2 In vivo Lipid Peroxidation 
It is generally accepted that measurement of conjugated dienes is a more 
reliable means to quantify the levels of l ip id peroxidation in vivo. Naturally occurring 
lipids exhibit simple end absorption in UV light as the wavelength is lowered toward 
200 nm and that the spectra of peroxidized lipids, however, are characterized by an 
intense K band near 233 nm. Through assessing the amount of peroxidized lipids, 
*• 
that is, the measurement of absorbance at 233 nm per mg lipid, the level of lipid 
peroxidation can be determined in vivo. 
It was found that when mice were challenged with CCl4 at 1 mVkg, maximum 
amount of peroxide produced, as indicated by levels of conjugated dienes, appeared 
transiently, in livers removed 30 min after the treatment with CCl4, but the rate 
decreased rapidly thereafter to a low level in livers removed after treatment with CCl4 
for 24 hr (Lee et al., 1982; Kim and LaBella, 1987). In agreement with earlier 
studies, significant increase of conjugated dienes was found in hepatic microsomes 
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Figure 2.3.6 Hepatic microsomal lipid peroxidation resulting from in vitro metabolism of 
CCl4 as measured by the formation of MDA. Microsomes were isolated from WT and K 0 
mice without any prior treatment. To the untreated microsomes (0.5 mg/ml), 2.36 mM CCl4 
in absolute ethanol and 1.1 mM NADPH were added to the reaction mixture in a fmal 
volume of 1 ml. The reaction mixture was incubated at 37°C for 15 min in dark. TBA assay 
was carried out by adding 0.5 ml of the above reaction mixture to 0.2 ml of 8% SDS, 1.5 ml 
of 20% acetic acid solution (pH3.5), and 1.5 ml of 0.8% aqueous solution of TBA. The 
reaction mixture was made up to 4.0 ml with distilled water which was then heated in a water 
bath at 95°C for 1 hr. After cooling to room temperature, the tube was centrifuged at 4000 
rpm for 10 min, the supernatant was taken and its absorbance at 532 nm was measured. 1，1， 
3，3-tetraethoxypropane was used as an extemal standard. The level of lipid peroxides was 
expressed as nmoles of MDA/mg protein/min. Data are mean 土 SD of five determinations. 
Differences in mean values were analysed by Student's /-test {P < 0.05). ** Statistically 
different from com oil (control) exposure {P < 0.01). 
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from the WT mice after treatment with CCl4 for 30 min (Table 2.3.2). There was a 
1.7-fold increase in the levels of conjugated dienes in WT mice treated with CCl4 for 
30 min, whereas there was no significant change in the peroxide levels in KO mice 
after treatment with CCl4 and the levels were comparable to the WT control group. 
The increase in the levels of conjugated dienes in WT mice after 30 min CCl4 
treatment was similar to that reported by other investigators (Lee et al,, 1982; Kim 
and LaBella, 1987). In contrast, no significant change in the levels of conjugated 
diene was found in the hepatic microsomes of WT and KO mice after 24 hr CCl4 
treatment. -. 
3.5 Hepatic Lipid Fatty Acid Composition 
3.5.1 Fatty Acid (FA) Composition in Hepatic Phospholipid (PL) 
It is commonly known that nearly all fatty acids in mammalian tissues have an 
even number of carbon atoms. Making use of this feature, internal standard of PL 
with 17 carbon atoms (C17:0) was used as a reference to calculate the levels of total 
hepatic PL and the individual FA in PL. A typical gas chromatogram of different 
fatty acids in hepatic PL is shown in Appendix 4. 
Our results showed that a significant alteration o fFA profiles in PL was found 
in the whole liver homogenate of WT mice after administration of 1 ml/kg CCl4 
(Table 2.3.3). The total PL in liver o f W T mice treated with CCl4 was significantly 
decreased for about 46% when compared with their controls. Saturated FAs including 
palmitic acid (16:0) and stearic acid (18:0) were both significantly decreased for 50% 
and 40% respectively in CCl4-treated WT mice as compared with the vehicle controls 
(Table 2.3.3). A l l other unsaturated FAs including oleic acid (18:ln-9), vaccenic acid 
(18:ln-7), linoleic acid (18:2n-6), dihomo-y-linolenic acid (20:3n-6), arachidonic acid 
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Table 2.3.2 Effects of different CCl4 time treatment on the levels of conjugated 
dienes formation in liver microsomes. 
Conjugated Diene Levels E'°^°„^ 
30 min exposure 24 hr exposure 
Strain Com oil 0 ¾ Com oil 0 ¾ 
WT 3.97 (士 0.51) 6.77 (土 1.40)* 2.80 (± 0.22) 1.79 (± 0 .77 f ' 
K 0 3.97(±0.83) 3.82 (±1.37严 1.88(±0.29) 3.74(±2.99严 
WT and K 0 Mice were injected intraperitoneally either with com oil (control) or 1 
mVkg CCl4. Thirty min or 24 hr after the injection, livers were removed from the 
mice and their levels of conjugated dienes were determined respectively. CCl4-
injected animals were compared with control animals at their corresponding time of 
CCl4 exposure. Data represent mean 土 SD of 3 determinations with 2 livers pooled 
for each determination. Conjugated diene levels E'"^ Vm are denoted as the absorbance 
at 233 nm through a 1 cm light path in a 1% solution of microsomal lipids from CCl4-
treated or control animals. Differences in mean values were analyzed by Student's t-































































































































































































































































































































































































































































































































































































































































































































(20:4n-6), eicosapentaenoic acid (20:5n-3), timnodonic acid (22:5n-3) and 
docosahexanoic acid (22:6n-3) were also decreased for about 40-57% in WT mice 
after C,Cl4 treatment except the palmitoleic acid (16:ln-7). The decrease in the level 
of PL was accompanied by the increase in MDA production indicating that the 
decrease in hepatic PL was due to lipid peroxidation and was possibly oxidized by 
reactive radical species during the process of metabolism 0fCCl4. 
In contrast to WT mice, no significant change was found in the levels of total 
hepatic PL in K 0 mice after the same dose of CCl4 treatment. CCl4 administration in 
K 0 mice did. not cause alterations in either the total hepatic PL content or individual 
group o fFA except for the 16:ln-7 which was slightly decreased to about 25% (Table 
2.3.3). As PL was regarded as the major substrate for peroxidation by radical species, 
our results indicated that mice which lack CYP2E1 expression were relatively 
resistant to CCl4-mediated lipid peroxidation. 
3.5.2 FA Composition in Hepatic Microsomal PL 
The PL in hepatic microsomal fraction was studied to localize the damage 
mediated by CCl4 in the smooth endoplasmic reticulum (SER) within the hepatocytes. 
A typical gas chromatogram of different fatty acids in microsomal PL is shown in 
Appendix 5. 
Our results showed the percentage decrease in the individual group of FA in 
PL o f W T animals was more intense in the microsomal fraction (60-86%; Table 2.3.4) 
than that in the whole liver homogenates (11-57%; Table 2.3.3). The depletion o fPL 
was probably localized in the microsomal region where CYP2E1 was found. On the 
























































































































































































































































































































































































































































































































































































































































































our hypothesis that the K 0 mice were more resistant to the CCl4-mediated lipid 
peroxidation since there was no significant alteration in FA composition either in 
whole liver homogenates or hepatic microsomes. 
3.5.3 FA Composition in Hepatic Triglyceride (TG) 
As shown from the gross liver morphology of WT mice treated with 1 mVkg 
CCl4 for 24 hr, the color of the livers was consistently changed from the normal 
reddish brown color to pale orange indicating the possibility of TG accumulation in 
the livers. This was confirmed by the biochemical quantitation of TG levels in the 
liver samples by gas chromatography as shown in Table 2.3.5. A typical 
chromatogram of different fatty acids in hepatic TG is shown in Appendix 6. 
In the present study, hepatic TG of WT mice after administered with 1 mVkg 
CCl4 was dramatically elevated. There was about 202% increase in the total TG level 
in livers of WT mice after CCl4 treatment as compared to their com oil controls. 
Moreover, nearly all FA groups in TG were subject to increases ranged from 143 to 
432% which were all significantly different from their control counterparts. 
The effect of CCl4 treatment on FA composition in hepatic TG levels in K 0 
mice was totally different from that of WT mice. There was no significant change in 
either the total TG content or individual FA level in K 0 mice administered 1 mWg 
CCl4. The lack of accumulation o fTG in livers o fKO mice challenged with CCl4 was 
in line with our observation from the gross liver morphology which showed that livers 
were not fatty. This result further supports that K 0 mice which lack CYP2E1 





































































































































































































































































































































































































































































































































































































































































































































































































































4.1 CYP2E1 is Required in CCl4-mediated Hepatotoxicity 
The toxic effects of CCl4 on the liver have been studied extensively over many 
years (Recknagel, 1967; Slater, 1984). The leading theory for the mechanism of 
cellular damage caused by CCl4 is that the compound is bioactivated by cytochrome 
P450 enzyme system in smooth endoplasmic reticulum to trichloromethyl free radical. 
This highly reactive free radical may readily interact with molecular oxygen to form 
trichloromethyl peroxy radical (McCay et al., 1984; Williams and Burke, 1990). 
These radicals are able to bind covalently to proteins and lipids, or removing a 
hydrogen atom from polyunsaturated fatty acids in lipid, thereby initiating lipid 
peroxidation and liver cell injury (Recknagel and Ghoshal, 1966; McCay et al., 1984; 
Williams and Burke, 1990). 
CYP2E1 has been, in particular, implicated to be the major cytochrome P450 
involved in CCl4-mediated liver injury based on previous studies using CYP2E1 
inducers and inhibitors. As these chemical inhibitors or inducers of CYP2E1 may 
have effects on factor(s) other than CYP2E1, direct evidence to verify the role of 
CYP2E1 -mediated CCl4 hepatotoxicity in vivo is needed. The purpose of the present 
studies was to determine the extent of CYP2E1 involvement in CCl4-mediated liver 
injury in vivo using a recently developed CYP2E1 -knockout mouse line, which lacks 
CYP2E1 expression (Lee et al., 1996). Any resultant toxicity, i f any, that developed 
in this mouse strain after CCl4 exposure cannot be attributed to hepatic CYP2E1. 
These studies clearly demonstrate that mice lack CYP2E1 activity were resistant to 
hepatotoxicity induced by CCl4 and support the earlier findings that CYP2E1 is the 
major factor involved in CCl4-mediated hepatotoxicity. 
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Results obtained from the studies of CYP2El-knockout mice strongly support 
the contention that CYP2E1 is required for the CCl4-induced hepatotoxicity in the 
wild-type (WT) animals. Although there was no significant difference in liver weight 
per body weight in WT mice after the administration of 1 mVkg CCl4, the color ofthe 
liver was found to change from the normal reddish-brown to abnormal pale orange. 
The liver damage induced by CCl4 was assessed by the serum ALT and AST activities 
which are regarded as good indicators of liver damage. Normally, ALT and AST 
activities are found within hepatocytes. An elevation of these activities in the blood 
(serum) may-represent any conditions that alter the permeability of cell membrane to 
such a sufficient degree that ALT and AST leak into serum and the increase is 
proportional to the number of affected hepatocytes (Hall, 1992). There were dramatic 
elevations in serum ALT and AST activities in WT mice after CCl4 treatment. On the 
contrary, at the same sublethal dose, 1 ml/kg CCl4 (Rao et aL, 1997), no such 
increases in serum ALT and AST activities were observed in mice lacking CYP2E1. 
Hence, this result implies CYP2E1 is required for the CCl4-induced liver injury. 
The lack of increases in serum ALT and AST activities in mice lacking 
CYP2E1 activity after CCl4 treatment was further supported by the observation that 
no liver necrosis was found in these animals. The primary lesion of CCl4 toxicity is 
characterized by centrilobular necrosis (Koch et al., 1974) and is dependent on the 
dose of the chemical (Rao et al., 1997). Our results and others (Rao et al., 1997) 
observed that CCl4 administered to the WT mice produces centrilobular necrosis and 
fatty degeneration of the liver. CCl4-induced necrosis is most severe in the 
centrilobular hepatocytes, as the concentration of cytochrome P450s in this region is 
the highest (Ingelman-Sundberg et al., 1988; Tsutsumi et al,, 1989; Buhler et al, 
1991). Also, it has been demonstrated that CYP2E1 induction was found to occur 
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primarily among perivenular hepatocytes (Tsutsumi et al., 1989) which are the same 
cells that exhibit most of the damage after exposure to ethanol, halogenated 
hydrocarbons and other CYP2El-activated hepatotoxicants (Lieber, 1991; Rao et aL, 
1997). This localization is consistent with the propensity of centrilobular liver 
damage to develop in alcohol abusers after exposure to various hepatotoxins, 
including ethanol itself (Lieber, 1992). 
In conclusion, the apparent lack of CCl4-induced hepatotoxicity in K 0 mice 
demonstrates that CYP2E1 activity is required for the initiation of CCl4-induced 
hepatotoxicity. The involvement of other isoforms of cytochrome P450 seems 
unlikely as CCl4 treatment causes no apparent liver damage in the absence of 
CYP2E1. 
4.2 CYP2E1 is Degraded following CCl4 Exposure 
It has been reported that treatment of animals (Tiemey et aL, 1992) and 
CYP2El-transfected HepG2 cells (Dai and Cederbaum, 1995) with CCl4 results in 
rapid loss o fPNP hydroxylase activity and immunoreactive CYP2E1. Similarly, a 
complete loss of CYP2El-catalysed PNP activity and immunoreactive CYP2E1 level 
was observed in WT animals after CCl4 administration in our study, suggesting that 
CYP2E1 is the target of destruction. No immunoreactive CYP2E1 was found in K 0 
mice as their genes are disrupted which result in no CYP2E1 expression (Lee et al., 
1996). Although CYP2E1 protein was not expressed in the microsomes o f K O mice, 
residual PNP enzyme activity was observed in the K 0 control group in the present 
study, suggesting that CYP2E1 only accounts for 86% of the PNP activity, while 
other enzymes may be involved in this catalytic reaction. Previous studies using 
cDNA-expressed human CYP2E1 enzymes have demonstrated that the conversion of 
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/7-nitrophenol is catalyzed predominantly (at least 85%) by CYP2E1 (Tassaneeyakul 
et al., 1993)，while CYP3A4 significantly contributes to the remaining PNP activity 
(Zeril l i et al., 1997). The fact that the loss of CYP2E1 protein and the decrease in 
CYP2E1 enzyme activity were closely related suggests that almost all of the labilized 
CYP2E1 protein is immediately degraded and removed from the endoplasmic 
reticulum (Dai and Cederbaum, 1995). 
Several mechanisms have been suggested for the inhibitory effect of CCl4 on 
/?-nitrophenol metabolism and CYP2E1 degradation in vivo. It has been suggested 
that CCl4 may suppress hepatic microsomal CYP2E1 synthesis and decrease enzyme 
activity. For example, the ethanol-inducible cytochrome P450 protein is more 
susceptible to destruction by CCl4 than the forms inducible by either phenobarbital or 
P-naphthoflavone (Gadeholt, 1984), but not all cytochrome P450 isozyme activities 
are depressed (Sohn et al., 1991). Specific reduction of CYP2E1 by CCl4 is not 
accompanied by a concomitant decrease in its mRNA which indicates a post-
translational destruction causing inhibition of the enzyme by its substrate (Sohn et al., 
1991). Although CCl4 can cause rapid loss of enzyme activity for several cytochrome 
P450s including CYP lA , CYP2C, and CYP2E1, it only induces a significant loss of 
protein for CYP2E1 (Sohn et aL, 1991). Other studies indicate that the rapid 
degradative pathway appears to be regulated by hormone-regulated phosphorylation 
o f CYP2E1 (Eliasson et al” 1990; Johansson et al., 1991; Eliasson et al., 1992). It 
was suggested that a ubiquitin-dependent degradation pathway could be involved in 
the rapid degradation of CYP2E1 labilized by CCl4 (Tiemey et al., 1992). 
Alternatively, CCl4 may act as a suicide substrate for CYP2E1. It has been shown that 
CCl4 may be metabolized in vivo and suppress CCl4 metabolism through the suicide-
inhibitory action of its metabolites (Levin et al., 1972; De Groot and Haas, 1981; 
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Manno et al., 1988). Lastly, the trichloromethyl free radical, which results from the 
homolytic cleavage of CCl4, may bind either at the heme group of cytochrome P450 
or at the active site ofthe enzyme near the heme group, thereby leading to inactivation 
(Yamazoe et al., 1979; Femandez et al., 1982). Therefore, it is still unclear as to 
which mechanism is involved in degrading CYP2E1 following CCl4 exposure. 
4.3 CYP2E1 is Required in CCl4-induced Lipid Peroxidation 
It is believed that CCl4 exerts its toxicity via a mechanism which is known as 
lipid peroxidation. Biological membranes which are particularly susceptible to lipid 
peroxidation owing to their high concentrations of polyunsaturated fatty acids (PUFA) 
(Plaa and Witschi, 1976; Koster et al, 1977; Recknagel et al., 1989). Many instances 
ofcellular damage ofbiomembranes, such as that associated with liver injury by CCl4, 
have been attributed to free-radical intermediates produced by the direct reaction of 
oxygen with unsaturated lipid (Recknagel et al., 1989). However, the precise role of 
lipid peroxidation in liver pathology has not been completely settled mainly because 
ofvariable effects 0fCCl4 in different animal species. In other words, the divergence 
in the response to CCl4 of various animal species pose a difficulty to investigate the 
mechanism of CCl4-induced liver damage. For instance, when rats are administered 
with CCl4, the levels of lipid peroxidation intermediates are increased. Nevertheless, 
in hepatic microsomes from mice, a species known to be highly susceptible to CCl4 
toxicity, conjugated dienes were not detectable 3 to 6 hr after administration of CCl4, 
suggesting that lipid peroxidation is not an important mechanism of CCl4-induced 
liver damage (Diaz-Gomez et al., 1975; De Toranzo et al., 1978). However, Lee et al, 
(1982) and K im and LaBella (1987) reported that hepatic lipid peroxidation does 
occur in mice, as in rats, when livers are examined 30 min after CCl4 administration. 
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Therefore, it is critical to determine the peak stage of lipid peroxidation after treating 
the animals with CCl4, otherwise, the effects of l ipid peroxidation may be overlooked. 
There are many different chemical indices of lipid peroxidation but of the 
many methods proposed for the detection of lipid peroxides in animal tissues, 
determination of conjugated dienes or TBA reactivity has been most widely 
employed. The spectrophotometric measurement of conjugated dienes is based on the 
rearrangement of 1,4-nonconjugated to the conjugated diene moiety of PUFA in 
membrane phospholipids during oxidation (Recknagel and Ghosal, 1966). The TBA 
method detects a variety of peroxides and unsaturated aldehydes which decompose 
under specified conditions of acid-heating to release MDA, which then forms a 
characteristic adduct with TBA that can be measured by absorption at 532 nm or 
fluorimetrically at 553 nm (Jose and Slater, 1972). 
As it has been demonstrated that TBA assay is well applied in determining the 
level o f l ipid peroxidation in vitro (Kim and LaBella, 1987)，to validate the hypothesis 
that CYP2E1 involves in lipid peroxidation and thereby leading to liver injury, it is 
essential to preliminarily screen out the peroxides as well as unsaturated aldehydes 
which are end-products of the peroxidation of PUFA in vitro. SER, organelle where 
CYP2E1 localizes, was isolated by differential centrifugation to microsomes. As seen 
from our results, in vitro incubation of CCl4 with the untreated hepatic microsomes 
isolated from WT mice significantly stimulated the production of M D A in the 
presence of CYP2E1 enzyme when compared with the residual levels in WT mice 
liver microsomes incubated only with vehicle control. The level of l ipid peroxidation 
was enhanced after CCl4 treatment in accompany with CYP2E1 in the hepatic 
microsomes which agrees with previous study using hepatic microsomes isolated 
from male F344 rat that CCl4 metabolism in vitro led to a significant increase in M D A 
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production (Allis et al., 1996). On the contrary, in K 0 mouse liver microsomes, in 
vitro treatment of CCl4 resulted in no significant increase in lipid peroxidation in 
comparison with its control counterparts. This result suggests that CYP2E1 plays a 
major role in CCl4-mediated lipid peroxidation in vitro. 
TBA assay is not suitable to be employed as a means to assess the level of 
lipid peroxidation in vivo (Janero, 1990). The spectrophotometric measurement of 
conjugated dienes is instead more often to be used in monitoring the extent of lipid 
peroxidation in vivo based on the rearrangement of 1,4-nonconjugated to the 
conjugated diene moiety ofPUFA in membrane phospholipids during oxidation (Lee 
et al., 1982; K im and LaBella, 1987). In our case, after exposing the WT mice to 
lml/kg CCl4 via intraperitoneal injection for 30 min, the amount of conjugated dienes 
from their hepatic microsomes extracted was significantly increased relative to its 
com oil vehicle control whereas the conjugated diene level returned to control level 
when the mice were exposed to CCl4 for 24 hr. Our results were in line with previous 
reports showing that higher levels of conjugated diene were detected in mouse livers 
after injecting with the same dose of CCl4 treatment for 30 min and the level of 
conjugated diene decreased thereafter to a low level suggesting the liver can 
metabolize lipid peroxides to an appreciable extent (Lee et al., 1982; Kim and 
LaBella, 1987). Alternatively, the low level of conjugated diene in WT mice after « 
exposed to CCl4 for 24 hr might reflect a late stage of lipid peroxidation as the 
endogenous defence mechanism was stimulated which was able to remove the 
reactive lipid peroxides. In fact, there have been some studies unable to detect 
conjugated dienes after exposing their animals to CCl4 but this may reflect the 
transitory nature of hydroperoxides in vivo, which appear to peak at 30 min and 
disappear by 3 hr (Diaz-Gomez et al., 1975; De Toranzo et al., 1978). 
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In contrast, when KO mice were injected with lmVkg CCl4 for 30 min and 24 
hr, no significant changes in the levels of conjugated dienes were observed as 
compared with its corresponding controls. Upon CCl4 treatment, the stimulation of 
the production of conjugated dienes which is a phenomenon of l ip id peroxidation only 
occurred in the presence of CYP2E1. These results implicate that CYP2E1 is required 
in CCl4-mediated lipid peroxidation. 
4.4 CYP2E1 is Required in CCl4-induced Hepatic Phospholipid Depletion 
The administration of CCl4 to our experimental WT animals is known to cause 
severe liver injury, such as centrilobular necrosis and fatty liver as supported from our 
histological data and the biochemical enzyme activities. Similar findings were noted 
in other studies (Recknagel and Glende, 1973; Ugazio et al., 1973; Recknagel et al., 
1977; Nava-Ocampo et aL, 1997). It is generally believed that the mechanism by 
which CCl4 exerts its hepatotoxic action is lipid peroxidation since significant amount 
of lipid peroxidation products, MDA and conjugated dienes, were detected in vitro 
and in vivo respectively. The peroxidative mechanism of polyunsaturated 
phospholipid (PL) has subsequently been of paramount concem in the pathobiology of 
lipid peroxidation because the structural phospholipids of cell membranes especially 
the microsomes where CYP2E1 is located have a high density of unsaturated PL. 
Exposure o f W T mice to CCl4 resulted in a significant loss ofPL. This finding 
is consistent with other earlier studies in rat (Sgoutas, 1967; Comporti et al., 1972; 
Lamb et al., 1984; Gebhart and Brabec, 1985). According to Lamb et aL (1984) and 
Glende et aL (1986), depletion of PL is closely related to the increase of hepatic 
phospholipase A and phospholipase C, enzymes responsible for the degradation of 
PL, and the decrease of sn-gleycerol-3-phosphate acyltransferase, an enzyme 
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responsible for the formation of PL in liver. It is thus not surprising to see a 
significant depletion in PL after CCl4 administration in our WT mice as PL was 
probably exhausted during the process of lipid peroxidation. The loss o fPL could be 
attributed to the activation of phospholipase A and phospholipase C (Lamb et al., 
1984; Glende et al., 1986). Although the exact mechanism is still unknown, there has 
been hypothesis suggesting that CCl4-mediated degradation of plasma membrane PL 
disturbed the hepatocellular calcium homeostasis. The membrane PL alteration could 
result in an influx of extracellular Ca〗+ into the cell. As cell Ca?+ rises, the 
intracellular -phospholipase-mediated degradation of hepatocellular PL may further 
disrupt the ability of mitochondria and the ER to sequester Ca:+ (Moore et al.’ 1976; 
Lamb et al, 1984). The increase in Ca^^  as a result of decreased Ca^^  sequestering 
capacity ofhepatocyte ER would activate phospholipases which serves as an activator 
of cofactor (Chien et al., 1980; Van den Bosch, 1980). Consequently, phospholipases 
were activated so that the rate of depletion o fPL was increased. Furthermore, there is 
evidence that accelerated PL degradation may be an important event in liver cell 
injury (Sugano et aL, 1970; Chien et al.’ 1978; Farber and Young, 1981; James et al, 
1982) as CCl4-dependent depletion of PL changes the structural and functional 
integrity ofhepatocytes (Lamb et aL, 1984). 
In addition, there have been in vitro and in vivo studies demonstrating the 
degradation of arachidonic acid (20:4n-6) as a result of lipid peroxidation after CCl4 
intoxication (de Toranzo et al., 1980; de Toranzo et al., 1981; Glende et al., 1986; 
Frank et al” 1987). Although there showed the greatest decrease in arachidonic acid 
in WT mice after CCl4 intoxication which was about 57%, the decrease was not so 
outstanding that all fatty acids in PL were lost in a similar level which was about 50% 
of the control level. 
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On the other hand, CCl4 treatment did not cause any depletion ofPL in K 0 
mice injected with CCl4. It is reasonable to have such findings since no detectable 
lipid peroxidation was observed in K 0 mice after CCl4 injection both in vitro and in 
vivo. This data indicate that CYP2E1 is required in CCl4-induced PL depletion. On 
the contrary, as seen from the FA profile in PL o fKO mice after injected with CCl4, 
there were no significant changes in all FAs except palmitoleic acid (16:ln-7). This 
should be highlighted for future investigation as palmitoleic acid was the only FA in 
PL that has no significant change after CCl4-int0xicati0n in WT mice. 
Our present findings in the microsomal PL showed an even more intense 
depletion as compared with that in whole liver homogenate isolated from WT mice 
after CCl4 administration. In microsomal PL, the percentage decreases ranged from 
60-86%, whereas the decreases ranged from 11-57% in whole liver homogenate from 
WT mice injected with CCl4. A l l FAs in microsomal PL were decreased indicating 
the site of CCl4-induced liver injury may be restricted in ER fraction where CYP2E1 
is localized. On the contrary, there was no change in all FAs in microsomal PL 
fraction o f K O mice after CCl4 administration indicating that CYP2E1 is required in 
CCl4-induced PL degradation. 
4.5 CYP2E1 is Required in CCl4-induced Hepatic Triglyceride Accumulation 
Our present results clearly showed the dramatic accumulation of triglyceride 
(TG) in WT mice after CCl4 treatment as compared to their com oil controls. These 
findings are consistent with earlier studies (Shimasaki et al., 1991; Merino et al., 
1996; Seishima et al., 1996; Honma and Suda, 1997). The failure of the liver to 
transport TG-rich low density lipoproteins into the plasma probably accounts for the 
accumulation o f T G within the liver (Recknagel et al., 1960; Pencil et al., 1984). This 
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inhibition of low density lipoprotein secretion no doubt arises from the structural 
disorganization of the ER due to the degradation of its major structural component, 
PL, which leads to a result that protein synthesis was blocked (Recknagel et al, 
1989). Moreover, there has been a hypothesis suggesting that as the destruction of 
structural component of the ER occurs, the hepatocellular calcium homeostasis is also 
disturbed. As a result, there is a mass influx of extracellular Ca?+ into the cells (Moore 
et al” 1976; Lamb et al., 1984). Besides, the calcium sequestration by the ER would 
be grossly depressed after CCl4 intoxication (Moore et al, 1976). A l l these may be 
additive and account for the rise in the cytosolic free Ca?+ which is believed to have 
profound inhibitory effects on protein synthesis which in tum blocks the secretion of 
low density lipoprotein responsible for transports of TG out of the cell into plasma 
(Recknagel, 1983). The livers then became fatty as TG were accumulated which 
made the liver color changed from the normal reddish brown color to pale orange. 
Moreover, it should be noted that all FAs in TG were increased after CCl4 
intoxication in WT mice except palmitoleic acid (16:ln-7), vaccenic acid (18:ln-7), 
dihomo-y-linolenic acid (20:3n-6) and timnodonic acid (20:5n-3). There seemed to 
have no selective accumulation in various FA groups in TG and this agrees with 
previous study (Shimasaki et al., 1991). 
Although accumulation o fTG was demonstrated in the livers o f W T mice after 
exposure of CCl4, a totally different picture was observed in mice lacking the 
expression of CYP2E1, that is, in K 0 mice. There was no significant alteration in the 
total TG content as well as individual FA in TG. These results were probably due to 
the increase in their resistant in CCl4-mediated lipid peroxidation as demonstrated in 
M D A and TBA assay. Protein synthesis and hence low density lipoprotein secretion 
were not disturbed since the organization and structure of membrane and membranous 
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organelle, ER, which is responsible for protein synthesis remained intact even after 
CCl4 exposure. Therefore, TG can be normally transported out of the cell making 
accumulation o f T G impossible. 
In conclusion, CYP2E1 is required in the CCl4-induced lipid peroxidation, and 
the resulting hepatic PL degradation and TG accumulation are responsible for the 
ultimate liver injury. 
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5. Conclusion 
With the previous efforts in searching for the isoform(s) of enzyme in the 
cytochrome P450 superfamily, including using various inhibitors to depress certain 
forms of enzyme activity or potentiators to enhance certain forms of enzyme levels, 
now we can confirm that CYP2E1 plays a main role in CCl4-mediated liver toxicity. 
In the presence of this enzyme, a single sublethal dose of CCl4 given to the WT 
animals produces a dramatic elevation in serum AST and ALT activities as a result of 
enzyme leaking from the damaged hepatocytes to blood. Moreover, necrotic and fatty 
livers were observed from both gross morphology as well as histological study. On 
the contrary, the K 0 mice lacking the expression of CYP2E1 enzyme were more 
resistant to CCl4-mediated liver injury as indicated by the lack of changes in their 
serum ALT and AST activities, and liver histology. Also, accumulation of 
triglycerides was shown in the livers of WT mice after CCl4 administration indicating 
that CCl4 metabolism is mediated via the action of CYP2E1 whereas no such finding 
was found in the K 0 mouse liver. These results implicate that CYP2E1 contributes to 
the largest extent in leading to CCl4-induced liver toxicity. 
Lipid peroxidation was observed in WT mice hepatic microsomes both in vitro 
and in vivo. Elevation in the levels of malondialdehyde in the hepatic microsome of 
WT mice incubated with CCl4 in vitro suggests that CYP2E1 metabolizes CCl4, 
thereby lipid peroxidation is initiated as a result of the formation of reactive free 
radical species and lipid peroxides. Significant high level of conjugated dienes, lipid 
peroxidation products, were found in the livers of WT mice after 30 min of CCl4 
treatment in vivo. On the contrary, no significant changes in malondialdehyde and 
conjugated dienes were found in K 0 mouse livers after 30 min or 24 hr CCl4 
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exposure. Therefore, we can conclude that K 0 mice, in the absence of CYP2E1, are 
resistant to CCl4-mediated lipid peroxidation as well as liver injury. 
In addition, CYP2E1 is required in CCl4-mediated hepatic PL depletion and 
hepatic TG accumulation. Significant depletion in PL and accumulation in TG were 
only demonstrated in livers of WT mice but not in K 0 mice after the same dose of 
CCl4 exposure. Also, as all FAs in the microsomal PL of WT mice after CCl4 
treatment were depleted even more intensely than that in whole liver homogenate 
suggesting that the site of CCl4-induced liver injury may be restricted in the ER 
fraction where CYP2E1 is localized. In contrast, no changes in all FAs in the 
microsomal PL fraction as well as in the hepatic TG of K 0 mice after CCl4 
administration indicating that CYP2E1 is required in CCl4-induced PL degradation 
and TG accumulation. 
In conclusion, CYP2E1 is an essential enzyme for bioactivation of CCl4. In 
other words, without the bioactivation of CCl4 by CYP2E1, CCl4 can be regarded as 
》.、.':^ ^ , •.‘,.> . . : -
i - - ‘ . 
non-heptotoxic to mice and hence lipid peroxidation cannot be initiated as the 
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formation of reactive radical species and lipid peroxides are blocked. Hence, 
CYP2E1 is the principal enzyme responsible for the CCl4-mediated hepatotoxicity. 
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Chapter III Chronic Ethanol Consumption Study 
1. Introduction 
1.1 Multiple Metabolic Pathways for Ethanol Metabolism 
Ethanol is primarily an exogenous compound that is readily absorbed from the 
gastrointestinal tract. When ethanol is consumed, only 2-10% of which absorbed 
from the gastrointestinal tract is eliminated through the kidneys and lungs and the 
remaining large portion is oxidized in the body, principally in the liver. Until three 
decades ago, it was generally believed that there was only one significant pathway for 
ethanol metabolism, involving multiple forms of alcohol dehydrogenase (ADH), an 
enzyme of the cytosol that catalyzes the conversion of ethanol to acetaldehyde, 
coupled with the reduction ofNAD+ to NADH (Figure 3.1.1.). It was known that 
catalase which is located in the peroxisomes is also capable of oxidizing ethanol in 
vitro in the presence of H2O2-generating system (Keilin and Hartree, 1945) (Figure 
3.1.1)，but under physiological conditions, catalase appeared to play a relative non-
significant role. 
Some features of ethanol metabolism, however, could not be explained on the 
basis of ADH or catalase, such as the adaptive increase after chronic consumption, 
therefore raising the suspicion of the existence of another pathway. In 1966，some 
investigators proposed that there may be a possible interaction of ethanol with the 
endoplasmic reticulum of the hepatocytes (also called microsomal fraction when 
obtained by ultracentrifugation) as shown from the morphological observation that in 
rats and humans, ethanol feeding leads to a proliferation of the smooth endoplasmic 
reticulum (SER) (Iseri et al., 1966; Lane and Lieber, 1966) which in particular, 
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(A) 
CH3CH2OH + NAD • CH3CHO + NADH + H+ 
ADH 
(B) 
CH3CH2OH + H+ + O2 • CH3CHO + NADP^ + 2H,O 
MEOS 
(C) 
NADPH + H+ + O2 ^ NADP+ + H^O^ 
NADPH Oxidase 
H2O2 + CH3CH2OH ‘ 2 H , 0 + CH3CHO 
Catalase 
(D) 
HYPOXANTHINE + H^O + O^ • XANTHINE + H A 
Xanthine oxidase 
H2O2 + CH3CH2OH ‘ 2H2O + CH3CHO 
Catalase 
Figure 3.1.1 Ethanol oxidation by alcohol dehydrogenase (ADH) and NAD (A), 
hepatic microsomal ethanol-oxidizing system and NADPH (B), a combination of 
NADPH oxidase and catalase (C), and xanthine oxidase and catalase (D). Adapted 
from Lieber, 1992 
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resembled that seen after the administration of a wide variety of hepatotoxins 
(Meldolesi, 1967)，barbiturates, and other therapeutic agents (Conney, 1967) and food 
additives (Lane and Lieber, 1967). As many of the substances that can induce the 
proliferation of the SER are metabolized, at least in part, by the cytochrome P450 
enzyme system that is located in the SER, the possibility that ethanol may also be 
metabolized by a similar process was raised. Such a system was then demonstrated in 
liver microsomes in vitro and found to be inducible by chronic ethanol feeding in vivo 
(Lieber and DeCarli, 1968; Lieber and DeCarli, 1970). The newly found inducible 
pathway of e.thanol metabolism in liver microsomes explained the metabolic tolerance 
to ethanol in the alcoholic. 
1.2 Metabolism of Ethanol by the Microsomal Ethanol Oxidizing System 
As early as 1968, Lieber and DeCarli described a microsomal ethanol-
oxidizing system (MEOS) in the liver which could be differentiated by various 
characteristics from ADH and catalase, the two other liver enzymes capable of 
metabolizing ethanol to acetaldehyde. Since then, this microsomal enzyme system 
has been subsequently characterized in detail. 
In the past, there has been a long standing debate on the basis that it might 
merely reflect either ADH or catalase contamination of the microsomes. Indeed, a 
series of studies established that the MEOS was distinct from both ADH and catalase, 
dependent on cytochrome P450 and, as for the other cytochrome P450 dependent 
microsomal monooxygenation reactions, that it utilized NADPH and oxygen. 
There is general consensus that the liver is the main organ capable of 
metabolizing most i f not all of the ingested ethanol. Due to the existence and function 
of three different liver enzymes metabolizing ethanol to acetaldehyde in vitro, the 
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question of the respective role of ADH, MEOS and catalase for ethanol metabolism 
under normal physiological conditions was to be answered. At present, there is no 
evidence for a significant role of catalase in ethanol metabolism as shown by various 
studies (Matsuzaki et aL, 1981; Shigeta et al.’ 1984; Takagi et al. 1985)，leaving ADH 
and MEOS as candidates for a concert action in alcohol metabolism. Reducing 
equivalents in form of NADH + H+ are being produced from oxidized NAD+ by the 
ethanol oxidation via ADH, and reducing equivalents in form of NADPH + H+ are 
consumed by the reaction through MEOS to yield oxidized NADP+. N A D H + I T may 
also functionr-as cofactor for MEOS although the ethanol oxidation rate is low (Lieber 
and DeCarli, 1970; Teschke et al, 1974，1975; Damgaard, 1982). 
It appears that ADH and MEOS are both dependent upon each other, and 
maximal ethanol-oxidizing capacity of the overall reaction is best achieved when the 
two enzymes are functioning. Investigators then try to determine the extent of 
contribution by these two systems. The extent of ethanol metabolism by ADH has 
traditionally been estimated by using A D H inhibitors such as pyrazole and its 
derivatives, and the pyrazole-sensitive ethanol metabolism was generally attributed to 
the action o f A D H (Lieber and DeCarli, 1972; Teschke et al., 1976; Teschke et al., 
1977). Inhibition of A D H may lower the production of reducing equivalents urgently 
needed for the ethanol oxidation via MEOS which may consequently metabolize less 
ethanol, overestimating thereby the role of A D H in ethanol metabolism and 
underestimating the importance of MEOS. In addition, the inhibitors may also 
suppress at intermediate and high concentrations MEOS activity (Teschke et al., 
1977; Takagi et al.’ 1986)，further underestimating the role of the MEOS (Lieber 
1983). 
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MEOS exhibits characteristics compatible with a significant role in ethanol 
metabolism under physiological conditions in which pH optimum in the physiological 
range, a K^ for ethanol o f 7-11 m M and near maximal activities at ethanol 
concentrations of 30 m M and above (Teschke et al., 1974)，a concentration which is 
commonly achieved in man after drinking. Moreover, MEOS is active even with low 
concentrations of NADPH and oxygen, since the corresponding K^ are found to be 
extremely low. As MEOS is also found in the human liver, and there is no question 
that ethanol can be metabolized by hepatic MEOS, but there was some uncertainty 
whether it actually does metabolize ethanol at an appreciable extent. 
There are several lines of evidence indicating that MEOS significantly 
contributes to ethanol oxidation in the liver. These include the increased rate of 
ethanol metabolism at high ethanol concentrations well above those needed to saturate 
A D H with a K^ for ethanol below 2 mM, suggesting the operation of a non-ADH 
pathway such as MEOS with high K^ for ethanol. Increasing ethanol metabolism 
with rising ethanol concentrations was found not only in the presence of an ADH 
inhibitor but also in its absence in isolated hepatocytes (Matsuzaki et al., 1981; 
Takagi et al., 1985), in liver slices (Thieden et al” 1971), in isolated perfused livers 
(Gordon, 1968)，and in vivo in man (Feinman et aL, 1978)，deermice (Takagi et al., 
1985), rats (Feinman et al., 1978)，and baboons (Pikkarainen and Lieber, 1980). In 
addition, the enhancement of ethanol metabolism at higher alcohol concentrations 
explains sporadic observations, which have then been confirmed that ethanol 
disappearance from the blood is not linear at high ethanol concentration that fully 
saturate the A D H pathway (Feinman, 1978). It is of note that A D H activity is 
strikingly depressed at intermediate and high ethanol concentrations under conditions 
when MEOS is extremely active (Teschke et aL, 1974). 
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The role of ADH and MEOS has further studied with the use of ADH-negative 
deermice congenitally lacking ADH (Bumett and Felder, 1980; Shigeta et al., 1983; 
Shigeta et al.’ 1984; Takagi et al” 1986). It was found that these ADH-negative 
deermice consume and metabolize (Shigeta et al,, 1984) ethanol at significant rates in 
the absence of ADH and in the presence of MEOS (Shigeta, 1984) under conditions 
where catalase was considered to play negligible role (Takagi, 1985). These studies 
well suggest that MEOS catalyses most i f not all of ethanol metabolism under these 
experimental conditions. The studies with the ADH-deficient mice also show that 
even in the absence of ADH but the presence and function ofMEOS, survival is still 
possible after chronic alcohol consumption. It is interesting that hepatic MEOS 
activity is increased in ADH-negative deermice compared to the ADH-positive strain 
(Shigeta et al., 1983; Shigeta et al, 1984). One may speculate that in the presence of 
both ADH and MEOS physiological substrate may be metabolized by both enzymes, 
and in the absence of ADH there is an enhancement of MEOS activity due to enzyme 
induction on the basis ofhigher substrate concentrations. 
Taken together and in line with previous studies, it is obvious that MEOS can 
fully account for the overall rate of ethanol metabolism in the absence ofhepatic ADH 
activity, and in its presence ethanol may be metabolized through MEOS up to 63%, 
especially at high ethanol concentrations. Moreover, under conditions where both 
MEOS and ADH are present, there is good evidence through a variety of experimental 
approaches that MEOS may again account for most i f not all of the enhanced ethanol 
metabolism, and the contribution via the ADH pathway may be small. 
1.3 Role of Cytochrome P450 2E1 (CYP2E1) in Ethanol Metabolism 
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A possible involvement of microsomal cytochrome P450 in MEOS activity 
has been suggested by indirect means in a variety of studies. An "ethanol-specific" 
form of cytochrome P450 was first suggested by the increase of a cytochrome P450 
species showing high affinity for cyanide after ethanol administration (Comai and 
Gaylor, 1973; Hasumura et al., 1975). Evidence in favor of an increase of a special 
form of cytochrome P450 after ethanol treatment was also derived from inhibitor 
studies (Ullrich et al.’ 1975). Later in 1977，it is found that there is a rise in 
cytochrome P450 involved a hemoprotein different from those induced by 
phenobarbital or 3-methylcholanthrene treatment. Moreover, the increase of a 
microsomal protein with size of 53,400 Da was found after ethanol treatment and was 
further partially purified from ethanol-fed rats which was more active for alcohol 
oxidation than the control (Ohnishi and Lieber, 1977). Similar findings were obtained 
from Joly and co-workers demonstrating that chronic ethanol administration to rats is 
associated with the appearance of a form of cytochrome P450 with spectral and 
catalytic properties different from those of the cytochrome P450 of control, 
phenobarbital-treated, and methylcholanthrene-treated rats which suggests that the 
possibility o f the involvement of another new form of isozyme of cytochrome P450 
(Joly et al., 1976，1977). An ethanol-inducible form of cytochrome P450, called then 
LM3a, purified from rabbit liver microsomes catalyzed ethanol oxidation at rates 
much higher than other cytochrome P450 isozymes (Koop et al” 1982; Ingelman-
Sundberg and Johansson, 1984). Similar results have been obtained with a hepatic 
cytochrome P450 isozyme (then called cytochrome P450j), purified from ethanol- and 
isoniazid-treated rats (Ryan et aL, 1985, 1986). Evidence was also provided for the 
existence of a cytochrome P450j-like isozyme in human (Wrighton et al, 1986; Song 
et al., 1987; Wrighton et al., 1987). Next, a purified human protein was obtained in a 
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catalytically active form, with a high turnover rate for ethanol (Lasker et al., 1987) 
which is later designated as cytochrome P450 2E1 (CYP 2E1) fNebert et al., 1987). 
The designation CYP2E1 should be reserved for this specific cytochrome P450 
alcohol monooxygenase. However, other microsomal cytochrome P450 isozymes can 
also contribute to ethanol oxidation (Lasker et aL, 1987; Salmela et cd., 1996). Thus 
the term MEOS should be maintained when one refers to the overall capacity of the 
microsomes to oxidized ethanol rather than to that fraction of the activity that is 
specifically catalyzed by CYP2E1. 
1.4 Role of Cytochrome P450 2E1 in Alcoholic Liver Disease and Associated 
Oxidative Stress 
As mentioned before, ethanol is metabolized by CYP2E1. However, the 
metabolites produced by the action of CYP2E1 sometimes involve more toxic 
intermediates than the precursors. Much of the medical significance ofMEOS and its 
ethanol-inducible CYP2E1 result not only from the oxidation of ethanol but also from 
the unusual and unique capacity of CYP2E1 to activate many xenobiotic compounds 
to their toxic metabolites, often free radicals, thereby contributing to the ethanol-
induced pathology. Indeed, microsomes from ethanol-fed animals exhibit much 
greater rates o fNADPH oxidation than microsomes from untreated animals (Feierman 
et al., 1985; Dicker and Cederbaum, 1988). Enhanced oxidase activity would result in 
the increased production of both superoxide anion and hydrogen peroxide which, in 
the presence of chelated iron, can produce reactive hydroxyl radicals (Feierman et al., 
1985; Dicker and Cederbaum, 1988) (Figure 3.1.2), though it is still not clearly 
demonstrated that a comparable uncoupling of CYP2E1 occurs in vivo. 
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Figure 3.1.2 Oxidation of ethanol in hepatocyte. Many disturbances in intermediary 
metabolism and toxic effects can be linked to 1) ADH-mediated generation o fNADH; 
2) induction of activity of microsomal enzymes, especially MEOS containing 
CYP2E1; and 3) acetaldehyde, product of ethanol oxidation. GSH, reduced 
glutathione; GSSG, oxidized glutathione; dashed lines, pathways that are depressed 
by ethanol; solid lines, stimulation or activation; -[，interference or binding. Adapted 
from Lieber, 1997. 
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CYP2E1 exhibits a unique ability to potentiate an iron-catalyzed Fenton-type reaction 
in a reconstituted system, and increased rates of hydroxyl radical-mediated 
metabolism of ethanol were observed for microsomes isolated from animals with 
induced CYP2E1 (Feierman et al., 1985; Dicker and Cederbaum, 1988). The 
increased capacity to produce active oxygen species was manifested by an increased 
rate of microsomal lipid peroxidation by microsomes or liposomes enriched in 
CYP2E1 (Krikun and Cederbaum, 1986; Ekstrom and Ingelman-Sundberg, 1989; 
Persson et al,, 1990). Antibody to CYP2E1 inhibited -65% ofmicrosomal peroxide 
production while almost completely inhibiting NADPH-dependent lipid peroxidation 
(Ekstrom and Ingelman-Sundberg, 1989). These results suggest that the participation 
of CYP2E1 is necessary for lipid peroxidation to be observed but more direct 
evidence is needed to confirm this. 
In view of the capacity of CYP2E1 to generate reactive oxygen intermediates, 
such as superoxide radicals (Figure 3.1.2) and the known toxicity ofthese free oxygen 
radical species, CYP2E1 plays a key role in the pathogenesis of liver injury. Indeed, 
Dai et al. (1993) carried out experiments to stable and constitutively express the 
coding sequence of the human CYP2E1 in HepG2 cells, a human hepatoma-derived 
cell line, infected with recombinant retroviral vector. Results indicated that the 
human CYP2E1 is especially reactive in production of reactive oxygen intermediates 
and in catalysis of lipid peroxidation. There is increasing evidence that ethanol 
toxicity is linked to the increased production of reactive oxygen intermediates as 
evidenced by enhanced lipid peroxidation. DiLuzio (1964) was one of the first to 
report that ethanol could produce increased lipid peroxidation in the liver and that the 
ethanol-induced fatty liver could be prevented by antioxidants (Diluzio, 1968). 
Several mechanisms by which ethanol could promote oxidative stress have been 
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suggested, including prominently increased generation of oxygen- and ethanol-
derived free radicals at the microsomal level, especially through the intervention of 
the ethanol-inducible CYP2E1 (Cederbaum, 1989; Nordmann et al., 1992). Indeed, 
CYP2E1 reduces oxygen to superoxide anion and HjOj in the absence of substrates 
for hydroxylation and even in their presence, since CYP2E1 is a leaky enzyme 
(Gorsky et aL, 1984; Ingelman-Sundberg and Johansson, 1984). 
Ethanol toxicity may be contributed by another way which is the increase in 
microsomal generation of active oxygen derivatives through radical-mediated 
inactivation of metabolic enzymes (Dicker and Cederbaum, 1988), including CYP2E1 
itself (Koop and Tiemey, 1990). Nevertheless, much evidence suggests that the 
toxicity associated with CYP2E1 involves the production of free radicals. The 
CYP2E1 -mediated ethanol metabolism to acetaldehyde was proposed to occur via 
hydrogen abstraction to form an a-hydroxyethyl radical intermediate (Ingelman-
Sundberg and Johansson, 1984). The lipid peroxidation initiated by CYP2E1 
contributes to oxidative stress in cells. However, the mechanisms relating CYP2E1-
dependent l ipid peroxidation to tissue damage are still speculative. It is known that 
the damage process involves Kupffer cells which are known to produce cytokines 
such as TGPP and TNFa which may initiate Ito cell activation and apoptosis in 
heptocytes. In a recent experiment, regional elevation of CYP2E1, TGFp and TNFa 
were observed after ethanol treatment, using the gastric infusion model to produce 
alcohol-related liver damage (Lindros et aL, 1993). A possible scheme for ethanol-
induced hepatotoxicity is presented in Figure 3.1.3. 
Part of the microsomal alcohol oxidation is mediated by hydroxyl radicals 
which are generated from superoxide anions and hydrogen peroxide, in a Haber-
Weiss-catalyzed reaction (Ingelman-Sundberg and Johansson, 1981). It appears that 
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Figure 3.1.3 Hypothetical scheme for the role o fCYP2E l in alcoholic liver disease. 
L ip id peroxidation initiated by the enzyme in the membranes causes the formation of 
reactive aldehydes and peroxides which can activate Ito cells for collagen production 
and Kupffer cells for cytokine production. This process is synergistically influenced 
by a diet containing unsaturated fat, which facilitates the process. Inflammatory 
responses and fibrosis might trigger the development of necrosis or apoptosis of the 
perivenous hepatocytes. (+ 二 stimulation). Adapted from Ronis et al.’ 1996. 
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the inducible microsomal alcohol oxidation catalyzed by CYP2E1 is to a great extent 
also mediated by a similar radical mechanism (Ingelman-Sundberg and Johansson, 
1984). The formation of a-hydroxyethyl radical from ethanol has been correlated with 
the oxidase activity of CYP2E1 (Albano et al.’ 1991) and could thus be an important 
factor in the development of alcohol-induced liver injury. Recently, it has been 
reported that about 80% of alcoholic cirrhotic patients have autoantibodies directed 
against the hydroxyl radical adduct to CYP2E1, as is evident from ELISA and 
Westem blot analysis (Clot et al, 1994). It might be possible that these antibodies, 
which are not seen among control individuals, contribute to the alcohol-mediated 
hepatotoxicity. 
1.5 Objectives o f the Study 
Needless to say, people are highly concerned about the liver toxicity as caused 
by chronic ethanol consumption. However, the mechanisms relating CYP2E1-
dependent lipid peroxidation to liver damage after chronic ethanol consumption are 
still speculative. It is believed that CYP2E1 plays a critical role in MEOS yet there is 
still lack of direct in vivo evidence to demonstrate the CYP2E1 -dependent liver 
toxicity by chronic ethanol consumption. 
Therefore, in the present study, by the use of the recently developed CYP2E1-
knockout mice which lack CYP2E1 expression (Lee et aL, 1996)，the involvement of 
CYP2E1 in chronic ethanol consumption-mediated hepatotoxicity was investigated. 
I f CYP2E1 is in fact the early determinant in ethanol-induced hepatotoxiciy, mice 
which lack CYP2E1 expression should be able to withstand any disturbances, i f 
occurred, in the liver. 
89 
2. Materials and Methods 
2.1 Chemicals and Materials 
Ethanol (95% purity) was obtained from Merck (Germany). Formalin, 
monobasic sodium phosphate, dibasic sodium phosphate, ethylenediaminetetraacetic 
acid (EDTA), sodium chloride fNaCl), were obtained from Riedel-de Haen 
(Germany). Absolute ethanol, phosphoric acid, methanol, chloroform, hexane, diethyl 
ether, toluene were obtained from BDH Laboratory Supplies (Dorset, England). Rat 
CYP2E1 ECL Westem blotting kit (Cat No. RPN 259) and 0.45 ^im nitrocellulose 
membranes *were obtained from Amersham Life Sciences (Buckinghamshire, 
England). A l l other chemicals were obtained from Sigma Chemical Company (St. 
Louis, MO). 
2.2 Animals 
CYP2E1 -knockout (K0) mice and their wild-type (WT) counterparts are 
inbred strains on Sv/129/ter genetic background (Lee et al., 1996). A pair ofparental 
stocks of K 0 and WT mice were shipped from the National Cancer Institute fNational 
Institutes of Health, Bethesda, MD, USA). They were then bred and reared at the 
Chinese University of Hong Kong animal rooms on a 12 hr light/dark cycle (06:00-
18:00) period. The animals were acclimatized for at least 1 week prior to the 
experiments which were then treated according to the experimental protocol. 
2.3 Chronic Ethanol Treatment 
2.3.1 Ethanol Diet Composition 
Lieber and DeCarli (1989) control and ethanol liquid diet formulations 
(Product No. F1259SP and F1258SP respectively) were purchased from Bio-Serv 
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(Frenchtown, New Jersey). The following caloric intake was provided by the 
composition of the control diet: 35% from fats, 47.0% from carbohydrates, 18.0% 
from protein and 0.0% from ethanol (Figure 3.2.1，Caloric profile), whereas the 
caloric intake was provided by the composition of the ethanol diet as 35.0% from fats, 
11.5% from carbohydrates, 18.0% from proteins and 35.5% from ethanol (Figure 
3.2.2, Caloric profile). The control diet, that is 0% ethanol derived calories (EDC) 
and ethanol diet of various %EDC were prepared according to recipe in Table 3.2.1. 
2.3.2 Ethanol Feeding 
Male WT and K 0 mice each divided into two feeding groups, control and 
ethanol diet, with 11 mice for each group. They were individually housed in shoebox 
cages and were first fed control liquid diet ad libitum for 14 days until their body 
weight gains were observed during the acclimatization period. The animals were then 
randomly assigned to control and ethanol diet feeding groups. Ethanol diet was given 
to the ethanol diet feeding group of both WT and K 0 mice, whereas control diet was 
given to the control diet feeding group. A l l ethanol diets were prepared daily, 
weighed and given to the ethanol diet recipients ad libitum. The ethanol diets were 
given in a step-wise increase as shown in Table 3.2.2. The ethanol diet was first 
supplemented with ethanol content (9% EDC) for the next 6 days after the 
acclimatization period, followed by a further increase in ethanol content to 12% EDC 
for the next 11 days and 18% for the next 11 days. Finally, the ethanol content was 
increased to 20% EDC and maintained for the rest of the experimental period (55 
days). The control animals were pair-fed, that is, the amount of control diet given to 
the control partner of a pair was dependent on the amount of ethanol diet that its 
partner consumed the day before. The food consumption for each mouse was 
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Figure 3.2.2 Caloric profile ofLieber and DeCarli (1989) ethanol liquid diet. 
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Table 3.2.1 Recipe for preparing 2000 ml of Lieber and DeCarli (1989) control and 
ethanol liquid diet. 
Ethanol Derived Weight of ethanol Weight ofcontrol Volume of95% 
Calories (%EDC) diet added (g) diet added (g) ethanol added (ml) 
0 ~ 0^0 4 5 U ^ 
9 66.7 338.3 33.5 
12 88.9 300.7 44.7 
18 133.4 225.6 67 
20 146.7 203.0 73.7 
A l l ingredients were mixed well in a plastic container and made up to 2000 ml with 
distilled water. 
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Table 3.2.2 The gradual increment and time of maintenance in the percentage of 
ethanol in liquid diet for the ethanol feeding group. 
Day Period Ethanol-derived Calories (EDC) % for 
ethanol feeding group 
M 4 ~ ~ ‘ 14 days 0 
15-20 6days 9 
21-32 11 days 12 
33-43 11 days 18 
44-98 55 days 20 
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recorded daily and the body weight and the blood ethanol level of each mouse were 
monitored biweekly. 
After 2 months of feeding, the mice were sacrificed by decapitation and blood 
was subsequently collected into 1.5 ml eppendorf tubes. Serum was obtained after the 
blood was allowed to clot at room temperature for 30 min and centrifuged at 3,000 
rpm for 20 min. The serum was reserved for less than a week in 4°C for 
determination of serum alanine aminotransferase and aspartate aminotransferase 
activities. The whole liver was excised, weighed, and a small section (〜1 cm〗 wide) 
was removed- from the median lobe and fixed in 10% formalin in phosphate buffered 
saline (PBS) for histopathological examination. The remaining liver lobes were 
snapped frozen, wrapped in aluminium foil, and stored in liquid nitrogen until used. 
2.4 Monitoring of Blood Ethanol Levels 
Blood ethanol levels (BELs) were monitored for each WT and K 0 ethanol 
recipients bweekly. A small wound was made on the mouse tail tip by cutting its tail 
for approximately 1 mm in length. About 50 ^il ofblood from the wound was drawn 
into a microvette® (Model No: CB300, Sarstedt, Germany) which is a small capillary 
tube pre-coated with 0.48 mg potassium-EDTA to prevent blood clotting. BEL was 
determined enzymatically by the rate of NADH production (Lundquist, 1957). 
Commercial ethanol kit (Cat. No. 332-UV) for BEL determination was obtained from 
Sigma Chemical Company (St. Louis, MO). Twenty microliters ofblood sample was 
used for the assay and the BEL assay was performed according to the manufacturer's 
directions. 
2.5 Preparation ofMicrosomal Fractions 
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A portion of the liver (〜0.6 g) was homogenized in 0.6 ml of ice-cold 
homogenizing buffer ^)H7.4) containing 10 mM Hepes, 1 mM EDTA, 1 mM DL-
dithiothreitol (DTT) and 10% (v/v) glycerol using a 1 ml-Telfon-glass hand-held 
homogenizer (Wheaton, USA). The whole liver homogenate was then centrifuged at 
10,000g (= 17,000 rpm) in a Beckman table-top ultracentrifuge (Model Optima™ 
TLX) equipped with a TLA 120.2 fixed angle rotor for 30 min. The supernatant was 
transferred to a new tube and centrifuged again at 100,000 g (= 55,000 rpm) for 40 
min. After the centrifugation, the supernatant was discarded and the pellet was 
resuspended -in resuspension buffer (RB) containing 0.1 M potassium phosphate 
buffer (pH7.4), 1 mM DTT, and 20% (v/v) glycerol. This suspension is referred to 
the microsomes and stored at -80°C until used for SDS-PAGE analysis. 
2.6 Determination ofMicrosomal Protein Concentration 
The protein concentration in the microsomal preparation was determined 
according to the microassay method by Bradford (1976). Bradford reagent was 
prepared by dissolving 100 mg Coomassie Brilliant Blue G-250 in 50 ml 95% ethanol 
and 100 ml 85% (w/v) phosphoric acid. The reagent mixture was further diluted to a 
final volume of 1000 ml and was filtered before use. A standard protein stock 
solution was prepared by dissolving 0.2 g bovine serum albumin (BSA) in 100 ml 
distilled water. From this stock solution, five different concentrations o fBSA ranging 
from 10 to 100 ^ig was prepared in 0.1 ml o fRB in 1.5 ml eppendorf tubes. To 0.1 ml 
of diluted microsomal preparations or BSA standard solutions, 1 ml of Bradford 
reagent was added in a 1.5 ml-eppendorf. This reaction mixture was vortexed and 
incubated at room temperature for at least 2 min (< 1 hr). The absorbance of each 
sample was measured at 595 nm using a Beckman DU7500 Spectrophotometer. A 
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BSA standard curve was constructed by plotting the corresponding absorbance against 
the BSA protein concentrations (p,g). A typical BSA standard curve is shown in 
Appendix 1. The protein concentration in microsomal sample was calculated from the 
standard curve obtained. 
2.7 Determination of Serum Aminotransferase Activities 
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
activities, markers for hepatotoxicity, were determined enzymatically by the rate of 
NADH disappearance (Bergmeyer et al., 1978). Commercial ALT and AST kits (Cat. 
No. 59-UV for ALT and Cat. No. 58-UV for AST) which were based on the 
optimization procedure as suggested by Bergmeyer et al. (1978) were obtained from 
Sigma Chemical Company (St. Louis, MO). Thirty-five microliters of serum sample 
was used for each assay. The ALT and AST assays were performed according to the 
manufacturer's directions. 
2.8 Liver Histology 
The chronic ethanol consumption-mediated hepatic damage was examined by 
histological study. Liver sections of approximate 1 cm^ wide were excised from the 
median lobe with a razor blade and the sections were subsequently fixed in 10% 
formalin buffered with I X PBS ovemight and then transferred to 70% (v/v) ethanol. 
The liver sections were then placed in increasing concentrations of ethanol, 70%, 
80%, 95% (v/v), each for 1 hr and then followed by 3 changes of absolute ethanol 
each for 25 min for complete dehydration. After dehydration, the liver sections were 
cleared in 2 changes of xylene each lasting for 25 min. Then the liver sections were 
transferred to 3 changes of molten paraffin each for 25 min and finally embedded in 
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paraffin using a Thermolyne Histo-Center (Model II-N), USA. On the next day, the 
embedded liver sections were then sectioned with a microtome (Leica, Germany) in 7 
p,m in thickness, mounted onto glass slides (Anchor, China) and dried in 60。C oven 
ovemight. On the following day, the glass slides with the dried liver sections were 
placed unidirectionally in a staining rack which was then completely immersed in 
different tanks of solutions following the sequences as shown in Figure 2.2.1. The 
hydrating steps were started from tank 1 to 7 in which the samples were immersed in 
each tank lasting for 3 min. The hydrated samples were then stained with 
hematoxylin -(tank 8) for another 3 min. Then they were quickly but gently rinsed 
under a running tap and were quickly dipped into tank 9 and removed. Subsequently, 
the samples were soaked in tank 10 for 2 min and rinsed again under a running tap 
immediately. The sections were then stained with eosin (tank 11) for 5 min and rinsed 
briefly under running water. The sections were dehydrated gradually by quickly 
dipping in 70%, 80%, and 90% ethanol from tank 12，13 and 14 respectively. The 
samples were then dehydrated in 3 changes of absolute ethanol (tanks 15-17) each for 
3 min. After complete dehydration, the sections were cleared by soaking in 3 changes 
of xylene (tanks 18-20) for 3 min each. A few drops of mountant (Canada Balasm) 
were placed onto the stained section which was then covered with a cover slip. The 
liver sections were then allowed to air dry for 2-3 days and examined under a light 
microscope. Assessment of liver injury was performed with the help of Professor W. 
Y. Chan from the Department of Anatomy, the Chinese University ofHong Kong. 
2.9 SDS-PAGE and Western Blot Analysis 
Liver microsomes (15 ^ig protein) were electrophoretically separated on a 12% 
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sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) according to Laemmli 
(1970). They were then electrophoretically transferred to 0.45 |am nitrocellulose 
membrane by semi-dry method according to the manufacturer's instructions (Bio-
Rad). The levels of immunoreactive CYP2E1 protein present in hepatic microsomes 
were measured using a rat CYP2E1 ECL Western blotting kit (Cat. No. RPN259) 
obtained from Amersham Life Sciences. The immunodetection procedure utilizes an 
anti-rat CYP2E1 (primary) antibody raised in rabbit, a biotinylated secondary 
antibody, a streptavidin-horseradish peroxidase conjugate and ECL Westem blotting 
detection reagents. The liver microsomes from isoniazid treated rats were provided in 
the rat CYP2E1 ECL Westem blotting kit and used as a positive control. A l l 
immunodetection steps were performed according to the manufacturer's directions. 
Positive immunoreactive signals were visualized by enhanced chemiluminescence on 
HyperfilmTM ECL (Amersham Life Sciences). 
2.10 Hepatic Lipid Fatty Acid Composition Analysis 
2.10.1 Lipid Extraction 
Total lipid was extracted from the liver according to Folch et al. (1956). 
Approximately 300 mg of liver was transferred to a clean 50-ml Falcon tube. Two 
milligrams of L-a-phosphatidylcholine diheptadecanoyl, internal standard of 
phospholipid (PL), and 1 mg of triheptadecanoin, internal standard of triglyceride 
(TG), were added to the Falcon tube. These internal standards were used to monitor 
the extraction efficiency. Chloroform/methanol (2:1，v/v) was added to the Falcon 
tube to a final volume o f l 5 ml. Three milliliters of 0.9% NaCl was added to the tube 
and the liver was homogenized using a polytron (Model PT-MR 3000 from 
Kinematica, Switzerland) for at least 1 min. The homogenate was mixed well by 
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vortexing and was then centrifuged at 2500 rpm using a Beckman centrifuge (Model 
GS-15R) equipped with a S4180 rotor for 5 min. The bottom organic layer containing 
the total lipid from the liver was then carefully transferred to a clean test-tube and was 
used subsequently for thin layer chromatography. 
2.10.2 Thin Layer Chromatography (TLC) 
The total lipid extract prepared from 2.10.1 was evaporated under a stream of 
nitrogen. Two hundred microliters of chloroform was then added to resuspend the 
lipid extracts. A hundred microliter aliquot was applied onto a TLC plate (Model SIL 
G-25 UV254 from Macherey-Nagel GmbH & Co. KG) by using a 50 ^il-capillary tube 
(Sigma) and different classes of lipid were separated by TLC. A drop o fPL and TG 
internal standard was added in the middle of the TLC plate as a reference. Then, the 
TLC plate was developed in a solvent mixture of hexane, diethyl ether and acetic acid 
in volume ratio of80:20:l for 45 min. The TLC plate was dried at room temperature 
under a safety ventilation hood. The plate was sprayed briefly with a thin layer of 
fluorescent dye (2', 7‘-dichlorofluorescein in 95% methanol) and dried at room 
temperature under a safety ventilation hood. The migrating positions of PL, 
cholesterol, free fatty acid, TG and cholesteryl ester were visualized under UV light. 
The areas corresponding to PL and TG were marked with a pencil and they were 
cratched out with a cutter and then transferred to different screw-cap methylation 
tubes. 
2.10.3 Methylation 
To esterify the lipids, the silica gels corresponding to PL and TG were 
removed from the TLC plate as done in section 2.10.2 and transferred to the labeled 
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screw-cap methylation tube respectively for methylation. To each of the tubes, 1 ml 
of toluene and 2 ml of boron trifluoride-methanol were added. The samples were 
heated in a heating block (Thermolyne) at 90°C for 45 min. The tubes were cooled to 
room temperature and which were then individually added with 5 ml hexane and 1 ml 
distilled water. The tubes were mixed well by vortexing and centrifuged at 2500 rpm 
using a Beckman centrifuge (Model GS-15R) equipped with a S4180 rotor for 5 min. 
The upper clear organic layer was transferred to a clean test tube and was then 
evaporated under a stream of nitrogen using a nitrogen evaporator (Organization 
Associates, Inc, USA). One milliliter ofhexane (AnalaR grade) was added to suspend 
the PL while 200 ]xl ofhexane was added to dissolve the TG. 
2.10.4 Gas Chromatography 
PL and TG of various carbon chain length were separated by gas 
chromatography after the methylation o fPL and TG (Section 2.10.3). The dissolved 
PL and TG were transferred to different 2-ml clear crimp vials (Hewlett Packard, 
USA) and sealed with caps (Hewlett Packard, USA). Gas chromatography (GC) was 
performed on a Hewlett Packard 6890 Series GC System equipped with a flame 
ionization detector and a Hewlett Packard-DSfNOWax (Cross-Linked PEG) 30 m x 
0.32 mm x 0.5 ^m capillary column (Part No. 19091N-213). Samples were injected 
in 3 p,l aliquots by an autosampler and injections were run under a constant flow of 
1.3 ml/min nitrogen as a carrier gas and a timed protocol initiated with an oven 
temperature of 150°C for 1 min. The oven temperature was then programmed to 
increase at a rate of l5°C/min to 200°C. This temperature was hold for 2 min and was 
finally heated up to 250°C for 5 min at a rate of 2°C/min. The temperature of the inlet 
and detector were 220。C and 275°C, respectively. For data acquisition and 
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processing, the HP Chemstation software package implemented on a HP Vectra 
486/33VL was used. PL and TG profiles were reported according to the length of 
carbon chain in mg PL and TG per g liver respectively. 
2.11 Statistical Analysis 
Differences in treatment means for the two strains of mice were analyzed by 
Student's paired r-test using SigmaStat Advisory Statistical Software (SigmaStat 
version 2.01, SPSS Inc., Chicago, IL). Statistical significance was determined at a 
level o fP<0.05 . 
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3. Results 
3.1 Average Food Consumption 
The food consumption for each individually caged mouse was monitored 
daily. There was about 8% increase in the average food intake for WT ethanol 
feeding group compared to its control (Table 3.3.1). Similarly, a 5% increase in 
average food intake was observed in K 0 ethanol feeding group compared to its 
control (Table 3.3.1). 
3.2 Average Ethanol Consumption for Ethanol Liquid Diet Feeding Group 
The average ethanol consumption for ethanol liquid diet feeding group was 
determined. There was a slight decrease (about 5%) in the average ethanol intake in 
K 0 mice as compared to WT ethanol feeding mice at 9%EDC. No significant 
difference in the average daily ethanol intake per body weight was found between WT 
and K 0 ethanol feeding group at other % EDCs (12%, 18% and 20%) maintained 
(Table 3.3.2). This result suggests that CYP2E1 does not play a role in affecting the 
chronic alcohol consumption in our SV/129/ter strain background mouse model. 
3.3 Body Weight Gain 
The body weight change of each mouse at different %EDC of ethanol diet was 
monitored (Figure 3.3.1). There was a significant increase in the body weight o f W T 
ethanol diet feeding mice after 6 days on 9%EDC. In contrast, their control 
counterparts had a mild decrease in their body weights. It could be due to the fact that 
WT ethanol feeding group was given with food ad libitum whereas the amount of 
food given to the control group was restricted to match with the ethanol recipients. At 
the same % EDC, however, there was no significant change in the body weight gain 
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Table 3.3.1 Average food intake in WT and K 0 mice during 2 months of chronic 
ethanol consumption. 
Average food consumption (g) 
WT ^ “ 
Mouse Control Ethanol Control Ethanol 
1 14.86 15.68 m 2 13.67 
2 14.54 15.97 13.32 14.07 
3 14.32 16.16 13.56 14.53 
4 15.17 15.72 13.78 15.40 
5 15.17 15.89 14.59 15.53 
6 ‘. 14.71 16.82 13.83 14.02 
7 14.54 15.26 14.67 15.31 
8 14.64 15.62 14.92 15.26 
9 14.37 15.27 14.56 14.54 
10 14.09 15.9 15.59 17.29 
11 14.60 14.75 
M e a n i S D 14.64±0.35~~15.83±0.45"* 14.23±0.76 14.94±0.99" 
Food consumption for each mouse was measured daily. Twenty WT mice were 
divided into two groups each with 10 mice either feeding with control or ethanol 
liquid diet. Twenty-two K 0 mice were divided into two groups each with 11 mice 
either feeding with control or ethanol liquid diet. Results are expressed as average 
food consumption for each mouse. Differences between control and ethanol diet 
feeding group in WT and K 0 mice were analysed by Student's paired r-test (P < 
0.05). ” P<0.01; ***P<0.001. 
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Table 3.3.2 Average ethanol consumption ofWT and KO mice at different % EDC. 
Average ethanol consumption (g ethanol / kg body weight) 
9% EDC 12% EDC 18% EDC 20% EDC 
Mouse ~ ~ W T KO WT ^ 5 WT KO WT ^ 5 ~ " 
1 S^ ^ 1 ^ n ^ i ^ r ^ r m 19.49 
2 8.37 7.77 10.81 11.22 16.08 16.27 17.48 18.01 
3 8.35 8.01 10.91 10.79 15.57 15.11 17.64 19.43 
4 8.50 6.82 10.85 12.18 15.68 17.01 17.70 19.05 
5 7.65 7.95 11.29 10.97 15.94 15.03 17.60 17.89 
6 8.56 6.92 12.79 10.32 17.45 14.43 18.16 16.74 
7 7.92 8.30 10.54 10.78 15.35 16.02 17.69 19.20 
8 8.32 8.14 10.72 10.48 15.97 15.22 17.88 17.45 
9 7.71 7.43 10.14 11.33 12.85 14.32 16.88 16.39 
10 8.15 8.22 10.80 10.28 14.42 14.88 18.45 16.52 
11 7.59 10.50 15.41 17.41 
Mean± 8.16土~~7.75±~~~10.98i~~11.01± 15.46土 15.45土 17.65± 17.96± 
SD 0.32 O.ST 0.70 0.70^^ 1.19 0.84^^ 0.47 1.18^^ 
Average ethanol consumption for each mouse was determined. Ten WT and 11 KO 
mice were fed with ethanol liquid diet. Results are expressed as average ethanol 
consumption per body weight for each mouse. Differences between WT and KO 
ethanol diet feeding mice were analysed by Student's unpaired r-test {P < 0.05). ( P < 




























































































































































































































































































































































































































































































































































































between K 0 mice feeding ethanol diet or control diet. When the %EDC was 
increased to 12% and then 18% and maintained for 11 days, no significant changes in 
the body weight gains of both WT and K 0 ethanol feeding groups were observed as 
compared to their corresponding pair-fed controls. However, when the %EDC was 
finally elevated to 20% and maintained for the rest of the experimental period, 
significant decreases in body weight were demonstrated in both WT and K 0 ethanol 
diet feeding groups. These indicate that although the food intake and hence the 
caloric intake was higher for both WT and K 0 ethanol recipients, they still had 
significant lojsses in their body weights when they were fed with 20% ethanol liquid 
diet for 2 months. 
3.4 Blood Ethanol Levels 
The blood ethanol levels (BEL) of the WT and K 0 ethanol diet feeding groups 
were monitored and the data are presented in Table 3.3.3. No significant differences 
in BEL were observed between WT and K 0 ethanol feeding mice at day 13, 20，34， 
53，59 and 73. Also, it should be noticed that a large variation in the BEL was existed 
among the WT and K 0 ethanol feeding mice during ethanol consumption ad libitum. 
The fluctuations in BEL in ethanol feeding mice might be due to differences in the 
amount of ethanol consumed and the time at which ethanol was consumed in different 
mice. 
3.5 Mortality, Liver Weight and Liver Color 
During the course of the experiment, one of the ethanol feeding WT mice died 
suddenly and we believed that it was not due to the effect o f ethanol treatment. For 















































































































































































































































































































































































































































































































































































































































































































































ethanol consumption in both WT and K 0 mice caused a significant increase in liver 
weight as compared to their corresponding controls (Table 3.3.4). There was 11.3% 
and 14.5% increases in liver weight in the WT and K 0 mice, respectively after 
chronically fed with ethanol liquid diet at 20%EDC for 2 months. 
No noticeable color change from the WT mice after chronic consumption of 
ethanol was observed when compared with their control counterparts (Figure 3.3.2). 
Also, in the case of K 0 mice, chronic administration of ethanol did not have 
noticeable change in liver color. The livers of both WT and K 0 mice control and 
ethanol feeding groups consistently remained in the normal reddish-brown color. The 
gross liver morphology of all ethanol recipients appeared normal. 
3.6 Serum ALT and AST Activities 
ALT and AST activities are hepatic enzymes that are released into the 
bloodstream when liver cells are damaged. To assess whether chronic ethanol 
consumption can lead to liver injury in our mouse model, serum ALT and AST 
activities were measured as markers of liver damage. In WT mice, chronic ethanol 
consumption resulted in no significant change in serum ALT and AST activities 
(Table 3.3.5) activities as compared with their control groups. In K 0 mice, on the 
other hand, there was a significant increase (37%) in serum ALT activities but not the 
serum AST activities after chronically administered with ethanol when compared to 
its control. However, both the serum ALT and AST activities in both WT and K 0 
ethanol recipients fell within the normal range of 200 and 400 RJ/L respectively (Hall, 
1992). These results suggest that chronic ethanol consumption did not result in 
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Figure 3.3.2 Representative of livers taken from WT and K 0 fed control or ethanol 
diet. The livers of all mice, WT (n=10) and K 0 mice (n= l l ) of both control and 







































































































































































































































































































































































































































































































































































































3.7 Liver Histology 
As there was negligible changes in semm ALT and AST activities, liver 
histology was done to confirm whether there was any mild liver damage as i f present 
after chronic ethanol consumption (Figures 3.3.3 A-H). The liver taken from the WT 
mouse fed with control liquid diet showed a normal histological appearance. The 
hepatic parenchyma was organized into anatomozing plates ofhepatocytes as cords of 
cells radially disposed about the central vein (Figures 3.3.3A and 3.3.3B). Between 
the cords of hepatocytes were sinusoids. Although occasional binucleated cells were 
found, most- of the hepatocytes exhibited one prominent nucleus with strongly 
eosionphilic cytoplasm. The nuclei of the hepatocytes were large with peripherally 
dispersed chromatin and prominent nucleoli (Figure 3.3.2B). When the WT mice 
were fed with 20% EDC ethanol diet for 2 months, the histological appearance of the 
liver following ethanol treatment (Figure 3.3.3C) was found to be similar to that of the 
WT animal on control diet except that small microvesicular droplets were 
occasionally observed in some hepatocytes of the ethanol-treated liver (Figure 
3.3.3D). No disruption to the radial arrangement of hepatic plates nor the sinusoids 
between the hepatic cords were observed. Lymphocytes infiltration, ballooning, 
fibrosis, and massive necrosis were not observed in the ethanol-fed liver taken form 
the WT mice. In K 0 mice, the liver taken from the control diet was grossly normal 
(Figures 3.3.3E and 3.3.3F). Histological examinations on the liver of the K 0 mouse 
demonstrated a histological appearance similar to that of the WT animal fed with 
control diet. Hepatocytes were arranged into lobules with sinusoids between the 
hepatic cords. No necrosis, ballooning, nor fibrosis was found (Figure 3.3.3F). When 
the K 0 mice were fed with the ethanol diet as WT mice, severe liver damages and 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































lobular disarray, collapse of sinusoids, lymphocyte infiltration, ballooning, fibrosis or 
massive necrosis was observed. However, hepatocytes with an accumulation of 
microvesicular droplets were occasionally found, especially in centrilobular regions 
(Figure 3.3.3H). In conclusion, negligible liver histological abnormality was 
demonstrated in both WT and K 0 mice after feeding with 20% EDC ethanol diet for 2 
months which were also comparably normal as found in WT and K 0 mice fed with 
control liquid diet. 
3.8 Western Blot Analysis 
Effect of chronic ethanol consumption on CYP2E1 level in both WT and K 0 
mice was determined by Westem blot analyses with rat anti-CYP2El IgG. An 
immunoreactive band of about 56 kDa expected for the CYP2E1 protein was found in 
WT control group (Figure 3.3.4A, lanes 2-5). This represents the constitutive basal 
level of CYP2E1 in the hepatic microsomes of WT mice. The 56 kDa 
immunoreactive CYP2E1 protein was however, enhanced after feeding the WT mice 
chronically with ethanol diet (Figure 3.3.4A, lanes 6-9) as compared to its control 
group (Figure 3.3.4A, lanes 2-5). On the other hand, as expected, there was no 
immunoreactive CYP2E1 proteins detected in the liver microsomes o f K O mice either 
fed with control (Figure 3.3.4B, lanes 1-4) or ethanol diet (Figure 3.3.4B, lanes 5-8) 
since the Cyp 2el gene was disrupted and hence no CYP2E1 protein were expressed 
in the K 0 mice (Lee et al., 1996; Valentine et al., 1996). 
3.9 Hepatic Lipid Fatty Acid Composition 
3.9.1 Fatty Acid (FA) Composition in Hepatic Phospholipid (PL) 
PL, the backbone o fa l l cellular membranes, can be strikingly altered by 
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Figure 3.3.4 Westem blot analysis of CYP2E1 expression in WT (panel A) and K 0 
(panel B) mouse livers after feeding with control diet or 20% EDC ethanol diet for 2 
months. Liver microsomal proteins (15 ^ig/lane) prepared from four control diet-fed 
(lanes 2-5) and four ethanol diet-fed (lanes 6-9) mice were subjected to SDS-PAGE 
and transferred to nitrocellulose membrane. Blots were probed with polyclonal rat 
anti-CYP2El. Isoniazid-treated rat liver microsomes were used as a positive control 
(panel B, +ve control). 
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ethanol (Yamada et al., 1985). Effects of chronic ethanol consumption on the FA 
composition in hepatic PL and total hepatic PL were investigated. The total PL 
extracted from WT mouse liver after feeding with ethanol liquid diet for 2 months was 
significantly increased (14.8%) when compared to their controls (Table 3.3.6). On the 
contrary, there was no significant change in the total hepatic PL of K 0 mice after 
chronic ethanol consumption when compared to their control counterparts (Table 
3.3.6). 
As seen from Table 3.3.6, after feeding the WT mice chronically with ethanol 
diet, all o f the FAs in hepatic PL examined were generally increased, except for 
18:ln-7 and 20:4n-6. The saturated FAs in PL, 16:0 and 18:0，were significantly 
increased for about 11.2% and 21.3% respectively for the WT mice fed ethanol diet. 
Also, the unsaturated FAs in PL in WT mice chronically fed with ethanol were also 
increased significantly. These include the 18:ln-9, 18:2n-6, 20:2n-6 and 22:6n-3 with 
respective increases of21.3%, 19.4%, 25% and 25.6%. However, there was a 28.9% 
decrease in 22:5n-3 in WT mice fed ethanol diet as compared to its control, but this 
drop could not counteract the increase in other FA that a general elevation in total FAs 
in PL was maintained. 
In K 0 mice chronically fed with ethanol liquid diet, there was no significant 
difference in the total hepatic PL as compared to their controls. Also, the FA profile 
in hepatic PL of the K 0 ethanol recipients was similar to their control counterparts. 
Except for a lower value of 18:ln-9 in the ethanol-fed K 0 animals, all of the other 
FAs in hepatic PL were not statistically different from their controls. 
To determine whether the ethanol fed animals were under oxidative stress, 
peroxidizability index (PI) was calculated. PI was calculated as an index of substrate 






















































































































































































































































































































































































































































































































































































































































































deterioration of FAs with more than two double bonds (Sagai et al” 1988). The PI 
was determined from the percentages of monoenoic, dienoic, pentaenoic and 
hexaenoic FAs in hepatic PL as follows: 
PI = (Monoenoic % x 0.025) + (Dienoic % x 1) + (Trienoic % x 2) + 
(Tetraenoic % x 4) + (Hexaenoic % x 8) 
The formula for PI is based on the in vitro maximal rates of oxidation of fatty acids 
reported by Holman et al., 1954. In our case, WT and K 0 mice fed with ethanol diet 
did not give rise to any significant change in their PIs when compared with their 
respective controls. The ease of peroxidation was not enhanced in our experimental 
model after feeding the WT and K 0 mice chronically with ethanol. 
3.9.2 FA Composition in Hepatic Triglyceride (TG) 
Fatty liver is usually one of the consequences of alcoholic liver disease which 
is caused by mainly the accumulation of TG. The liver i f it is fatty, is usually 
characterized by a pale orange color resulting from TG infiltration to the liver. 
Although the color of the livers in both WT and K 0 experimental group remained in 
normal reddish-brown color, we were interested to know i f any early infiltration or 
accumulation of TG did occur, hence, the TG content as well as its FA profile were 
studied. 
As seen from Table 3.3.7，there was no significant change in the total hepatic 
TG after feeding the WT mice with ethanol diet at 20% for 2 months when compared 
to their controls. The data suggest that there was no indication of infiltration or 
accumulation o f T G in the livers o f W T mice chronically fed with ethanol. Similarly, 
in the case o f K 0 mice, there was no significant change in the total hepatic TG as 










































































































































































































































































































































































































































































































































































































































































































































































consumption in our mouse model, both WT and KO mice, did not cause any alteration 
in the total hepatic TG content. In addition, there was no significant change in the FA 
compositions in both WT and KO mice fed ethanol diet as compared to their 
corresponding controls. In conclusion, chronic ethanol consumption in our 
experimental model did not alter the FA composition in TG or the total TG content 
within the liver. These results implicate that chronic ethanol consumption did not 
result in any TG accumulation in both of our SV/129/ter WT and KO mouse strains. 
125 
4. Discussion 
4.1 Nutrients Displacement after Chronic Ethanol Consumption 
Ethanol itself provides substantial energy which accounts for 7.1 kcal/g 
(Lieber, 1998). In our study, ethanol represents 9%, 12%, 18% and 20% of total 
dietary energy intake. When the concentration was maintained to lower level, that is 
9-12%, there showed no significant loss in the body weights of ethanol recipients as 
compared with their controls. However, when ethanol represented 20% of total 
energy intake and maintained for two months, both WT and KO mice fed with ethanol 
diet were subject to a significant losses in their body weights. The body weight 
changes reflected their nutritional status. Monahan et al (1997) reported that 
C57BL/6 mice maintained on diets of 25% EDC gained as much weight as did the 
control whereas mice receiving 33% EDC diet did lose a significant amounts ofbody 
weights. These findings suggested SV/129/ter mice were unable to maintain their 
body weights even when 20% EDC diet was given whereas C57/BL/6 mice were able 
to keep their body weight gain even when 25% EDC diet was provided. In other 
words, SV/129/ter mice might suffer from serious weight losses i f more than 20% 
EDC diet were given to them leading to severe nutrient depletion. In fact, when 
ethanol represents 20% of the total dietary energy intake, many normal nutrients of 
the diet may be displaced which may result in primary malnutrition (Lieber, 1998). In 
addition, alcohol may impair the activation and utilization of nutrients which may also 
account for the body weight losses after ethanol consumption. Although ethanol is 
rich in energy which is almost as energy-dense as fat, yet chronic ethanol 
consumption of substantial amounts of ethanol is not associated with the expected 
effect on body weight (Lieber, 1991). Hence, in our study, chronic ethanol 
consumption produced a nutritional depletion status in both WT and KO mice. 
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4.2 Varied Blood Ethanol Levels after Chronic Ethanol Consumption 
During the continuous feeding of ethanol in our mice, there was no significant 
difference in BEL between WT and K 0 ethanol recipients. Also, there showed a 
great divergence in BEL between WT and K 0 ethanol recipients. Others reported 
BEL do not reach a steady-state level but instead fluctuates in a pattem characterized 
by widely varying levels ofless than 10 mg/dl and greater than 400 mg/dl (Tsukamoto 
et al., 1985). This might be due to the fact that they were administered with ethanol 
ad libitum. -• There might be a great difference on the time of ethanol intake. 
Moreover, there was a great variance in their own metabolic rates, that may further 
give diverging results. 
4 3 Increase in CYP2E1 Levels after Chronic Feeding ofEthanoI in WT mice 
MEOS is generally believed to be the principal metabolic pathway for ethanol. 
The first indication of a possible interaction of ethanol with the endoplasmic 
reticulum of the hepatocyte which is also called microsomes when obtained by 
ultracentrifugation was provided by the morphological observations that in rats and 
humans, ethanol feeding results in a proliferation of the SER (Iseri et al., 1966 and 
Lane and Lieber, 1966). SER is basically a membranous organelle in which its major 
component is phospholipid. Therefore, it is not surprising to find that in our study, 
WT mice after chronically administered with ethanol, their phospholipid content was 
increased which is probably as a result of proliferation of SER. This suggests that 
ethanol metabolism would lead to a consequence of proliferation of SER as the 
enzyme responsible for the metabolism is located in the SER fraction. In addition, the 
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enzyme for the metabolism of ethanol should then also be enhanced in their levels and 
this seems to be supported by our findings in the Westem Blot analysis. 
It has been reported that chronic feeding of animals with ethanol results in the 
increase in the level o fCYP2El suggesting the possible involvement of this isozyme 
of cytochrome P450 in ethanol metabolism. In fact, CYP2E1 is believed to be the 
principal isozyme taking part in the microsomal ethanol oxidizing system (MEOS) 
due to its inducibility by ethanol (Tsutsumi et al., 1989). After two months of feeding 
with ethanol in diets containing 20% EDC in our WT mice, CYP2E1 level was 
significantly..enhanced in their hepatic microsomes as shown from Westem Blot 
analysis. Induction of CYP2E1 was demonstrated in our WT ethanol feeding mice 
which is in line with previous studies using rat as a model fNanji et aL, 1994). On the 
other hand, no immunoreactive CYP2E1 was observed in all KO mice as their genes 
are disrupted which result in no CYP2E1 expression (Lee et aL, 1996). 
There have been several mechanisms suggested for the mechanisms for the 
increase in CYP2E1 after chronic ethanol consumption. These include the proposal of 
increased enzyme synthesis and decreased enzyme degradation (Tsutsumi et aL, 
1993). However, the regulation of CYP2E1 expression is regarded as complex, 
involving transcriptional, post-transcriptional, and post-translational events. 
Investigators using rabbits (and some involving rats) appeared to have ruled out 
transcriptional activation of the cyp2el gene or stabilization of the cyp2el mRNA as 
possible mechanisms, since ethanol had little effect on cyp2el transcript content in 
liver (Song et al., 1986; Khani et al., 1987; Song et al., 1987; Johansson et aL, 1988; 
Porter et al., 1989). A post-translational mechanism, namely protein stabilization, 
was thus proposed, since ethanol was found to prevent the rapid decrease in CYP2E1 
enzyme level that occurs in rat hepatocytes upon primary culture and acetone 
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treatment was shown to prolong the in vivo half-life of CYP2E1 in rat liver by 
eliminating the fast-phase component associated with the enzyme's normal 
degradation (Song et al., 1987). Furthermore, in a HepG2 cell line, which stable and 
constitutively expresses the coding sequences of human CYP2E1, addition of ethanol 
(2-100 mM) for 2 days resulted in an increased CYP2E1 content as determined by 
Westem blotting, whereas Northern blot analysis showed no raised CYP 2E1 mRNA. 
These results indicated that ethanol probably increases the content of CYP2E1 in the 
experimental model by stabilization of the protein against degradation (Carroccio et 
ai., 1994). Similarly, a FGC-4 hepatoma cell line exhibited basal levels of CYP2E1 
apoprotein that were inducible by ethanol treatment, but there was no observed rise in 
cyp2el mRNA levels, suggesting that CYP2E1 is increased by ethanol through post-
transcriptional mechanisms (McGehee et al” 1994). In conclusion, as the induction 
mechanisms of CYP2E1 by ethanol are so complicated, they are, however, still the 
subject of debate. 
4 4 Lack of Evidence Indicating the Development of Ethanol-mediated Liver 
Injury 
4.4.1 No Elevations in Serum ALT and AST Activities 
In our study, SV/129/ter strain male mice were used as a model to study the 
pathological status of liver after chronic ethanol consumption. Our present findings 
showed 1.12- and 1.16-fold increases in liver weights in WT and K 0 mice 
respectively after feeding with 20% EDC of diets for 2 months. Similar findings was 
shown by the study done by Odeleye et al (1991) that there was a tendency of an 
increase in liver weights of C57BL/6 mice fed with the diet containing 30% of 
calories as ethanol for 13 weeks. Also, our results are consistent with Holsapple et al 
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(1993) that increase in liver weights of (C57 BL/6 x C3H) F1 mice was observed after 
feeding with 36% EDC liquid ethanol diet for 42 days. However, the lack of 
increases in both serum ALT and AST activities in WT mice did not support our 
hypothesis that chronic ethanol consumption would lead to liver injury. As seen from 
our results, the serum ALT and AST activities, the two well-documented serum 
enzyme activities as indicators of liver injury, were not significantly increased after 
the WT mice were chronically fed with ethanol diet. In contrast, there have been 
studies demonstrating a significant increase in serum ALT activity after chronic 
feeding of animals with ethanol liquid diet implicating damages in hepatocytes 
leading to the leakage of enzymes to the bloodstream (Odeleye et al., 1991; Sarphie et 
iz/.，1997). On the contrary, although there was a slight increase in serum ALT 
activities in K 0 ethanol recipients as compared with their controls, the serum AST 
activity remained unchanged after chronic ethanol consumption. In addition, all 
serum ALT and AST activities remained within the normal reference range for mice 
as suggested by Hall (1992). No conspicuous indication of liver damage was 
demonstrated even feeding the mice with 20% EDC ethanol diet for two months. 
4.4.2 Normal Liver Histology 
To further confirm whether there was any liver injury present in our mice after 
ethanol consumption, histopathological study was done. As shown from our 
histological data, it clearly showed that no fatty liver was observed in WT and K 0 
mice after chronic feeding with ethanol diet. Besides, no indication of ballooning, 
fibrosis or massive necrosis was observed in the liver of both WT and K 0 ethanol 
recipients. In other words, no histological anomalies were shown even after feeding 
the WT and K 0 animals with 20% EDC liquid ethanol diet for 2 months in which 
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their livers remained comparably normal to their control counterparts. The results 
obtained, in fact, were beyond the scope of our expectation as fatty liver was 
developed in other animal models after chronic ethanol consumption. For instance, 
Lieber and DeCarli (1989) demonstrated in rats fed ethanol (36% EDC) for one 
month, fatty liver was observed. Also, Tsukamoto et al (1986) and French et al. 
(1986) were able to demonstrate alcoholic liver disease development in their rat model 
after feeding the animals for 4 and 6 months respectively. However, inconsistency of 
results obtained should be noticed as another studies by feeding the baboons with 
ethanol in the Lieber-DeCarli liquid diet did not result in cirrhosis (Ainley et aL, 1988 
and Porto et al, 1988). Similarly, Zidenberg-Cherr et al. (1989) were also unable to 
induce alcoholic liver disease nor fatty liver by feeding the miniature pig with diets 
containing 12 % EDC for 20 months. 
4.4.3 Lack of TG Accumulation 
Fatty infiltration of the liver occurs in rats after the prolonged ingestion of 
ethanol in spite of a nutritionally adequate liquid diet (Lieber and Rubin, 1969). 
Marked elevation of hepatic TG would be shown indicating the liver is fatty after 
chronic ethanol consumption (Walker and Gordon, 1970). Similarly, we assessed the 
hepatic TG levels to see i f any accumulation of TG occurred. Our results showed a 
general increase in total hepatic TG levels in WT and K 0 ethanol recipients yet there 
were no statistical differences found when compared with their corresponding 
controls. In fact, the accumulation o f T G was mild in WT and K 0 mice after chronic 
ethanol intake as there would be about 10-fold increases shown in other studies i f fatty 
liver is developed (Walker and Gordon, 1970; Lieber and DeCarli, 1976; Goheen et 
al., 1981; Tsukamoto et al., 1984; Odeleye et al, 1991). However, the mild 
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elevations in TG may account for the increases observed in the liver weight after 
chronic ethanol intake in both WT and KO mice. Many investigations have shown 
similar results that dramatic hepatic TG accumulation after feeding the animals with 
ethanol (Walker and Gordon, 1970; Lieber and DeCarli, 1976; Goheen et al., 1981; 
Tsukamoto et al.’ 1984; Odeleye et aL, 1991). It has been suggested that TG 
accumulates after chronic consumption of ethanol as hepatic lipogenesis is stimulated 
(Hi l l et al., 1960; Wiegand et al., 1973; Triscari et al., 1978; Tsukamoto et al,, 1984). 
Alternatively, others proposed that the accumulation o f T G is due to the alterations in 
the physical- properties of hepatic membranes structure, a factor linked to the 
development of hepatic fatty infiltration and etiology of ethanol-mediated liver 
damage (Lieber, 1984; Lieber and Savolainen, 1984). Nevertheless, until now, there 
was still no consensus made on the mechanism of ethanol-induced TG accumulation 
in liver and further investigation is needed. 
4.4.4 Elevations in Hepatic PL 
There are numerous conflicting reports concerning the effects of chronic 
ethanol intake on total hepatic PL levels. For instance, Furuno et al (1978) reported a 
decrease in PL in K K mouse liver after chronic ethanol consumption. Cunniingham et 
al. (1982) demonstrated a fall in palmitic acid (16:0) but a rise in dihomo-y-linolenic 
acid (20:3n-6). On the other hand, Odeleye et al (1991) reported an elevation in total 
PL amount after chronic feeding the mice with 25% and 30% EDC of diets. Until 
now, no general consensus has been made on the reason for the changes in hepatic PL 
levels after chronic ethanol consumption. However, rises in phospholipase A and 
phospholipase C activities were shown O^anji et al., 1994) leading to a decrease in 
liver arachidonic acid level of PL in which this phenomenon may suggest the 
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occurrence of l ipid peroxidation after chronic ethanol intake (French et al., 1970; 
Zidenberg-Cherr et al., 1991). Alternatively, the proliferation of membranous 
organelle, ER, in which its major structural components is PL, may be responsible for 
the rises in hepatic PL after chronic ethanol consumption. It is because chronic 
ethanol intake leads to the proliferation of SER as CYP2E1 was induced (Iseri et al, 
1966 and Lane & Lieber，1966). As shown from our results, the increase in hepatic 
PL was only demonstrated in WT mice fed with ethanol but not in K 0 mice of the 
same treatment. These results further support that as only the mice with proliferation 
of ER wi l l lead to the increase in hepatic PL. Moreover, it should be noted that there 
was no selective increases in any particular FAs in PL suggesting the increase is due 
to the proliferation of membranous organelle, ER. 
Furthermore, from the PL analysis, the peroxidizability index (PI), that is the 
ease ofthe fatty acids being oxidized, was calculated. PI did not increase significantly 
in both WT and K 0 mice after chronic ethanol consumption when compared to their 
corresponding controls. As proposed by Zidenberg-Cherr et al (1989), the defence 
mechanism would be stimulated when the miniature pigs were fed chronically with 
ethanol in diets containing 12% EDC for 20 months. The phospholipid profile was 
shifted that the proportion of unsaturated PL was significantly decreased whereas, the 
proportion of saturated phospholipids were decreased. As a result, membranes were 
rendered less susceptible to l ipid peroxidation in miniature pigs. The oxidative stress 
imposed by ethanol metabolism in that case evoked a protective response as 
characterized by altered phospholipid composition ofmembranes (Zidenberg-Cherr et 
al., 1989). However, in our case, no such defence mechanism was shown which 
suggests that after feeding the SV/129/ter strain male mice with 20% EDC ethanol 
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diet, a relatively insignificant oxidative stress was posed by chronic ethanol 
consumption. 
4.5 Possible Reasons for the Absence of Liver Damage after Chronic Ethanol 
Consumption in our Mouse Model 
Liver injury after chronic ethanol intake was demonstrated by many studies 
using various animal models but not all. For instance, when baboons were fed with 
Lieber and DeCarli ethanol liquid diet, liver cirrhosis was developed (Lieber et aL, 
1975) whereas, rhesus monkeys fed essentially the same diet did not (Mezey et aL, 
1983). In ad4ition, in the study as done by Lieber and DeCarli (1989), fatty liver was 
observed in male Sprague-Dawley rats after feeding with 36% EDC of ethanol liquid 
diet for one month. When we compared the dosage of ethanol administered to the rats 
in Lieber and DeCarli (1989) study and the SV/129/ter mice in our study, 12-18 g 
ethanol per kg body weight was consumed by each rat daily whereas, each mouse 
consumed about 20 g of ethanol per kg body weight in our study. In this case, the 
daily amount of ethanol consumed should be comparable to that of rat model even 
when we only maintained the ethanol diet at 20% EDC instead of 36% EDC as in the 
case ofrat model. Also, two months of feeding was ‘long-term, enough for our mice 
as their average life span was about 2 years (Hall, 1992). However, negligible liver 
injury was observed both from WT and KO mice with this alcohol feeding condition. 
The absence of ethanol-induced liver damage in our mouse model could be 
explained by the fact that they have a higher metabolic rate which requires a relatively 
higher dose of alcohol (that is 25 g/kg/day) to be administered in order to maintain a 
high blood alcohol level. Such a dose of alcohol, on the other hand, displaces the 
calories derived from nutrients and thus induces a malnourished state. This could be 
supported from the body weight data obtained in our study that the mice were 
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gradually suffer a body weight loss in both WT and K 0 mice. Also, from our daily 
observation of the mouse health status, i f we continually increased the %EDC to a 
higher value, the mice would become very vulnerable to death. Our mice should then 
be regarded here, not so suitable for the study of ethanol-induced liver damage. 
Moreover, similar results were obtained by Furuno et al. (1975) that no remarkable 
fatty liver was produced by ethanol drinking through a free access to a 15% ethanol 
solution as a drinking fluid for 2 weeks by using ICR, DBA/Ta, C3H/Ta, CFl/Ta and 
C57 BL/6J/Ta strains of mice as models. Mice should then be proposed here, not so 
suitable for the use in the study of ethanol-induced liver damage. 
Nevertheless, a complete different picture is demonstrated from the study by 
Furuno et al (1975). They found that there was an increase in hepatic lipid content in 
K K mice by being allowed free access to a 15% ethanol solution as drinking fluid 
even for only 2 weeks and fatty liver was developed when the study was continued for 
28 weeks. Also, Odeleye et al. (1991) reported that there were hepatic TG 
accumulation and elevation of serum ALT activities observed in C57 BL/6 female 
mice after feeding with 25% EDC ofLieber and DeCarli (1989) liquid diet for 13 
weeks. Also, Smith and Hoy (1990) found that mild to moderate liver steatosis was 
demonstrated in both male and female BALB/C, C57BL/6 and C3H/HeJ strains mice 
after feeding the animals with 30% ethanol liquid diet for 10 weeks. Similarly, Chen 
et al. (1993) showed a significant increased in hepatic TG levels after feeding C57 
BL/6 female mice with 31% EDC of the same liquid diet for 5 weeks. Moreover, 
Holsapple et al. (1993) demonstrated similar results that fatty liver was developed in 
(C57 BL/6 X C3H) F1 female mice after feeding with 36% EDC of the same liquid 
diet. Furthermore, Sarphie et al (1996) also found the abnormalities in the functional 
and structural aspects ofthe liver after feeding BALB/C mice for 56 days with Lieber 
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and DeCarli (1989) ethanol-containing (4% w/v) liquid diet. Hence, the absence of 
ethanol-mediated liver damage in our mouse model is in fact quite astonishing. The 
only major difference between our model and others is the genetic background 
difference. KK, BALB/C, and C57BL/6 strains of mice are relatively more sensitive 
to the ethanol challenge whereas, SV/129/ter mice, that is the one that we used, were 
relatively insensitive to chronic ethanol consumption in our case. In fact, we have 
recently found that SV/129/ter mice were even insensitive to 3-methylcholanthrene-
mediated injury in which this compound is a well-known hepatotoxin (Lee et al., 
unpublished -.data). Therefore, the SV/129/ter strain mice are considered not so 
suitable for studying the role ofCYP2El in alcohol-induced liver injury. 
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5. Conclusion 
Chronic ethanol consumption induced a proliferation of SER which was 
indirectly supported by the increase in the total hepatic phospholipid content due to an 
enhancement of the metabolic enzyme system for ethanol being located in SER. In 
addition, chronic ethanol consumption induced the CYP2E1 levels as shown from 
Westem Blot analysis although the induction mechanism still needs a long way of 
study. 
Nevertheless, there was no conspicuous alcohol-mediated liver injury 
observed after feeding our SV/129/ter male mice at 20% EDC for two months. Not 
only the serum AST and ALT activities of WT mice fell within the normal reference 
range but also the K 0 mice who were chronically administered with ethanol using 
Lieber-DeCarli Method of feeding. Although there was a slight increase in serum 
AST activities in K 0 mice after feeding with ethanol, the evidence was not strong 
enough to derive a relationship between the vulnerability after chronic ethanol 
consumption and the presence or the absence of CYP2E1. Also, our histological 
findings demonstrated that there were no apparent indication of liver damage, and no 
significant increase in hepatic triglyceride content in both WT and K 0 mice after 
ethanol consumption. These results reject the possibility to establish the deduction of 
the resistance of K 0 mice to alcoholic liver damage due to the absence of CYP2E1 
enzyme. 
Furthermore, the absence of the depletion of phospholipids and changes in 
fatty acid composition in hepatic PL in both WT and K 0 mice after chronic ethanol 
intake suggesting that neither lipid peroxidation nor defence mechanism was initiated. 
In other words, there was no conspicuous indication of early stage nor the late stage of 
alcoholic liver injury in both WT and K 0 mice as the hepatic PL was not depleted and 
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PI was not significantly altered suggesting they were under negligible oxidative stress. 
Hence, both our WT and K 0 mice can be regarded as insensitive to chronic ethanol 
consumption-mediated hepatotoxicity. 
The lack of indication of liver injury-mediated by chronic ethanol 
consumption may probably due to the high metabolic rate of SV/129/ter strain mice 
that the amount of ethanol consumed in both WT and K 0 mice were relatively not 
‘high’ enough to maintain a sufficiently high blood alcohol level to develop ethanol-
induced fatty liver. However, i f the dose of ethanol is increased to 25 g/kg/day as 
suggested (Lieber and DeCarli, 1989) to maintain a high blood alcohol level, such a 
dose of alcohol wi l l displace the calories derived form nutrients and thus induces a 
malnourished state. Hence, our mice should be considered not so suitable to be 
employed as a model to study alcoholic liver disease. Indeed, there have been many 
studies showing the development of alcohol-mediated hepatotoxicity in C57 BL/6, 
BALB/C, K K mice and so on. The inconsistency of our results may be attributed to 
the insensitivity of the strain of the mice used in the present study. Therefore, it is 
suggested that SV/129/ter mice are not suitable to serve as a model in the study of 
chronic ethanol consumption-mediated hepatotoxicity despite its success in the CCl4 
study. However, the underlying mechanisms for their relatively insensitivity to 
ethanol challenge still need to be investigated. 
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Chapter IV CONCLUDING REMARKS 
1. A Comparison between Acute Carbon Tetrachloride Study and Chronic 
Ethanol Consumption Study 
1.1 Regulation of CYP2E1 Expression 
CCl4 and ethanol are both the substrates of CYP2E1 but they exhibit their 
hepatotoxic effects in a very different way. The first divergence that should be 
highlighted may be that after the exposure of CCl4 or ethanol, liver CYP2E1 levels 
would be depleted in the former case but enhanced in the latter condition. CYP2E1 
on one hand can metabolize CCl4 but on the other hand, it commits a suicidal 
mechanism that is degraded by the action of CCl4. The fact that the loss of CYP2E1 
protein and the decrease in CYP2E1 enzyme activity were closely related suggests 
that almost all ofthe labilized CYP2E1 protein is immediately degraded and removed 
from the endoplasmic reticulum (Dai and Cederbaum, 1995). Specific reduction of 
CYP2E1 by CCl4 is not accompanied by a concomitant decrease in its mRNA which 
indicates a post-translational destruction causing inhibition of the enzyme by its 
substrate (Sohn et al., 1991). In contrast, CYP2E1 level is induced after chronic 
ethanol consumption. Proliferation of ER as well as an increase in CYP2E1 are 
observed after the exposure of ethanol. Moreover, the regulation of CYP2E1 
expression after chronic ethanol consumption, unlike after CCl4 exposure, is complex, 
involving transcriptional, post-transcriptional and post-translational events, instead of 
post-translational regulation in case 0fCCl4 exposure. 
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1.2 Free Radical Production Involved in CCl4- and Chronic Ethanol 
Consumption-Mediated Liver Injury 
It is generally believed that CCl4 and ethanol are both activated by the action 
of CYP2E1. Interestingly their resulting intermediates become relatively more toxic 
than their respective parent compound. For instance, CCl4 is activated by CYP2E1 
that CCl3. is formed which is much more reactive than its parent compound, CCl4, and 
is likely to react with molecular oxygen to form a even more reactive species, 
CCl3OO.. Similarly, ethanol is metabolized by CYP2E1 and OH formation is 
resulted. AU those radicals produced as a consequent of metabolism of CCl4 or 
ethanol are believed to play a important role in initiating events of lipid peroxidation. 
Moreover, the CCl4- and chronic ethanol consumption-mediated liver injury are 
somehow stimulated by the lipid peroxidation events that fatty liver or even necrosis 
which are the ultimate damages to liver. 
1.3 An Overall Comparison between CCI4 Study and Chronic Ethanol 
Consumption Study 
Although same strain of animal, SV/129/ter, was used in the two studies, the 
effects of acute CCl4 exposure and chronic ethanol consumption on ethanol 
consumption on liver hepatotoxicity were indeed greatly varied (Table 4.1). As 
shown from our results, serum ALT and AST activities, indicators of liver injury, 
were significantly elevated in WT but not in KO mice after acute CCl4 exposure (1 
ml/kg). Similarly, abnormalities in liver histology were clearly found in WT mice 
after CCl4 exposure. On the contrary, when the WT and KO mice were fed with 
ethanol liquid diet for two months, negligible changes in semm ALT and AST 

























































































































































































































































































































































































































































SV/129/ter genetic background are suitable to be used as a model to study the role of 
CYP2E1 in CCl4-mediated liver toxicity but not in chronic ethanol consumption-
mediated liver injury. 
2. Future Studies 
2.1 Acute CCl4 Study 
2.1.1 Calcium Homeostasis Studies 
Disturbance in lipid metabolism, including accumulation of TG and depletion of 
PL, could be..a secondary mechanism in CCl4 toxicity, and this may probably due to the 
alteration in calcium homeostasis. Hence future work is needed to determine whether 
hepatotoxic agent like CCl4 causes a redistribution of hepatocyte Ca?+. The method of 
Tsien et al. (1980) using fluorescent indicator "quin-2" and the method of Murphy et al. 
(1980) using arsenazo I I I could be useful in the study of calcium homeostasis after CCl4 
intoxication in our WT and K 0 mouse model. 
2.1.2 Spin Trapping Studies 
Although liver damage was clearly shown in WT mice after CCl4 exposure, the 
underlying mechanism on how the free radical leading to such damage could be further 
investigated by using spin trapping technology. Through this technique, free radicals 
produced as intermediates of CCl4 mechanism in the presence of CYP2E1 expression can 
be identified and to determine whether this action is blocked in CYP2El-knockout mice. 
2.2 Chronic Ethanol Consumption Study 
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2.2.1 Generation of a Heterozygous "Ethanol-Sensitive" Mouse Strain (SV/129/ter 
X C57BL/6) 
Our results showed SV/129/ter strain mice were resistant to develop ethanol-
induced liver damage after chronic ethanol consumption and were in conflict with many 
other reports published using mice from different strains. For instance, C57BL/6 mice 
were reported to be able to develop ethanol-induced liver injury after chronic ethanol 
consumption. Hence, making use of this, we could try to obtain heterozygous "ethanol-
sensitive" offsprings by mating C57BL/6 strain mice which are sensitive to ethanol with 
SV/129 ter strain mice which are regarded to be insensitive to ethanol-induced toxicity. 
Interesting results might be obtained as the heterozygous "ethanol-sensitive" offsprings 
could probably be able to develop liver injury after chronic ethanol consumption. 
3. Concluding Remarks 
The CYP2El-knockout mouse model on SV/129/ter genetic background was 
proven to be very useful for confirming the role of CYP2E1 in CCl4-mediated liver 
injury. However, the role of CYP2E1 in alcohol-induced liver injury could not be 
confirmed in our mouse model. 
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11 Timnodonic acid (22:5n-3) 
12 Docosahexaeonic acid (22:6n-3) 
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A typical gas chromatogram of different fatty acids in hepatic microsomal PL. 
Peak identification key 1 Palmitic acid (16:0) 
2 Palmitoleic acid (16:ln-7) 
3 Heptadecanoic acid internal standard (17:0) 
4 Stearic acid (18:0) 
5 Oleic acid (18:ln-9) 
6 Vaccenic acid (18:ln-7) 
7 Linoleic acid (18:2n-6) 
8 a-Linolenic acid (18:3n-3) 
9 Dihomo-y-linolenic acid (20:3n-6) 
10 Arachidonic acid (20:4n-6) 
11 Eicosapentaenoic acid (20:5n-3) 
12 Timnodonic acid (22:5n-3) 
13 Docosahexaeonic acid (22:6n-3) 
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A typical gas chromatogram of different fatty acids in hepatic TG. 
Peak identification key 1 Myristic acid (14:0) 
2 Palmitic acid (l6:0) 
3 Palmitolic acid (16:ln-9) 
4 Palmitoleic acid (16:ln-7) 
5 Heptadecanoic acid, internal standard (17:0) 
6 Stearic acid (18:0) 
7 Oleic acid (18:ln-9) 
8 Vaccenic acid (18:1 n-7) 
9 Linoleic acid (18:2n-6) 
10 a-Linolenic acid (18:3n-3) 
11 Gadoleic acid (20:ln-9) 
12 Dihomo-y-linolenic acid (20:3n-6) 
13 Arachidonic acid (20:4n-6) 
14 Eicosapentaenoic acid (20:5n-3) 
15 Timnodonic acid (22:5n-3) 
16 Docosahexaeonic acid (22:6n-3) 
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